Urinary system disorder
MONDO:0002118A disease involving the renal system.
Also known as: disease of renal system, disease or disorder of renal system, disease, urinary tract, disease, urologic, disease, urological, diseases, urinary tract, diseases, urologic, diseases, urological
4758 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
Showing the 400 most recently updated of 1166 trials in this tab.
-
Needle-Free DNA vaccines aim to stop deadly Rodent-Borne viruses
⭐️ VACCINE ⭐️ CompletedThis study tested two DNA vaccines designed to prevent hemorrhagic fever with renal syndrome caused by Hantaan and Puumala viruses. A total of 132 healthy adults received up to four doses of vaccine using a needle-free jet injector. The main goal was to see if the vaccines trigge…
Phase: PHASE2 • Sponsor: U.S. Army Medical Research and Development Command • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:35 UTC
-
Engineered immune cells aim to trick the body into accepting a new kidney
Disease control CompletedThis trial tests a new cell therapy called TX200-TR101 in people who receive a kidney from a living donor. The therapy is made from the patient's own immune cells, which are genetically modified to help the body accept the donated kidney instead of rejecting it. The study focuses…
Phase: PHASE1, PHASE2 • Sponsor: Sangamo Therapeutics • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Can a website help cancer survivors live healthier? large study tests online lifestyle coaching
Disease control CompletedThis study tests whether a secure website with educational sessions, goal-setting, and tracking tools can help survivors of several cancers (including breast, prostate, colorectal, and others) improve their diet, increase physical activity, and manage weight. Participants are age…
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Two-Drug immunotherapy combo shows promise for advanced kidney cancer
Disease control CompletedThis study tested a combination of two immunotherapy drugs—high-dose interleukin-2 (IL-2) and pembrolizumab (Keytruda)—in 27 adults with metastatic kidney cancer. The goal was to see if the combination could shrink or eliminate tumors. Participants received both drugs in a coordi…
Phase: PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Drug that starves tumors shows promise against advanced kidney cancer
Disease control CompletedThis phase II trial tests the drug lenalidomide (CC-5013) in people with advanced or inoperable kidney cancer. Lenalidomide works by cutting off blood flow to tumors, which may stop or slow their growth. The study aims to see how many patients respond to treatment and what side e…
Phase: PHASE2 • Sponsor: The Cleveland Clinic • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New drug duo aims to shrink advanced kidney tumors
Disease control CompletedThis phase 2 trial is testing a new drug called cadonilimab (AK104), either alone or combined with axitinib, as a first treatment for advanced or metastatic kidney cancer. The study includes two parts: one testing different doses of cadonilimab alone in various kidney cancer type…
Phase: PHASE2 • Sponsor: Akeso • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Can a drug stop kidney disease from returning after transplant?
Disease control CompletedThis study tested whether the drug Acthar can prevent focal segmental glomerulosclerosis (FSGS) from coming back in people who receive a kidney transplant. Fifteen adults with FSGS and advanced kidney disease took part. Researchers measured how many had FSGS return by looking at …
Phase: PHASE3 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Experimental fetal fluid therapy aims to save babies born without kidneys
Disease control CompletedThis trial tests whether repeatedly adding sterile fluid into the womb can help fetuses with severe kidney failure grow enough lungs to survive after birth. Pregnant women with early pregnancy kidney failure can choose to receive the infusions or just be monitored. Babies who sur…
Phase: PHASE1 • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Promising combo tackles tough cancers in early trial
Disease control CompletedThis early-phase study tested the safety of combining two drugs—pembrolizumab (an immunotherapy) and AMG386 (which targets blood vessel growth)—in 62 people with advanced solid tumors like melanoma, ovarian, renal, or colorectal cancer. The main goals were to find the safest dose…
Phase: PHASE1 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New drug aims to shield kidneys during heart surgery
Disease control CompletedThis study tests a single dose of ravulizumab given before heart surgery to see if it can prevent kidney damage and serious kidney problems in people with chronic kidney disease. About 736 adults will take part. The goal is to reduce the risk of major kidney events within 90 days…
Phase: PHASE3 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Can a Nurse-Led program reverse frailty in dialysis patients?
Disease control CompletedThis study tests whether a 3-month nurse-led program can reduce frailty and improve self-management in people undergoing peritoneal dialysis. The program includes personalized assessments, education, exercise training, and social support. Researchers compare this program to stand…
Phase: NA • Sponsor: Henan University • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Nanoparticle chemo and DNA-Repair blocker join forces against tough cancers
Disease control CompletedThis trial investigates a combination of two drugs: EP0057, a chemotherapy drug wrapped in a nanoparticle to help it reach cancer cells, and olaparib, which stops cancer cells from fixing DNA damage. The study includes adults with small cell lung cancer, bladder cancer, or prosta…
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Smaller tube, same stone removal: new kidney stone surgery tested
Disease control CompletedThis trial compares two surgical techniques for removing kidney stones that are 2 to 4 centimeters in size. The newer method, called suction mini-PCNL, uses a smaller tube and suction to remove stone fragments, while the standard method uses a larger tube. The goal is to see if t…
Phase: NA • Sponsor: The First Affiliated Hospital of Guangzhou Medical University • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New combo approach for kidney cancer shows promise in early trial
Disease control CompletedThis study tested a two-step treatment for medium-sized kidney tumors (4.1-7 cm). First, doctors blocked the tumor's blood supply, then froze it. The goal was to see if this approach is safe and works well. 25 adults with stage T1b kidney cancer took part. The main focus was on s…
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Which drug works better after infant valve surgery? new study compares mirabegron and oxybutynin
Disease control CompletedThis study looked at two drugs, mirabegron and oxybutynin, in 52 children over age 3 who had surgery for posterior urethral valves. The goal was to see which drug better improves bladder and kidney function and reduces urinary tract infections. Researchers also checked safety by …
Phase: NA • Sponsor: South Valley University • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New drug cocktail aims to slow kidney disease
Disease control CompletedThis study tested whether adding balcinrenone to the standard drug dapagliflozin helps people with chronic kidney disease more than dapagliflozin alone. 324 adults with kidney disease and protein in their urine took either a combination pill or dapagliflozin alone for 12 weeks. R…
Phase: PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New drug cocktail aims to beat bladder cancer recurrence
Disease control CompletedThis phase 3 trial tests whether a combination of enfortumab vedotin and pembrolizumab, given before and after bladder removal surgery, works better than standard chemotherapy for muscle-invasive bladder cancer. About 800 participants will be randomly assigned to one of the two t…
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New hope for FSGS? obinutuzumab trial targets tough cases
Disease control CompletedThis phase 2 trial tested the drug obinutuzumab in 20 adults with a kidney disease called primary FSGS. The participants had not responded well to or could not take standard treatments like steroids. The goal was to see if obinutuzumab could reduce protein leakage in the urine, a…
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New hope for advanced bladder cancer? bevacizumab combo tested
Disease control CompletedThis phase 3 trial tested whether adding bevacizumab (Avastin) to standard chemotherapy (gemcitabine and cisplatin) helps people with advanced urinary tract cancer live longer. 506 patients with cancer that had spread or could not be removed by surgery took part. The study compar…
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Bladder cancer drug combo shows promise in patients who Can't have chemo
Disease control CompletedThis phase 2 trial tested a combination of two drugs—TAR-200 (placed directly into the bladder) and cetrelimab (an immunotherapy given by IV)—in 163 people with muscle-invasive bladder cancer who were scheduled for bladder removal surgery and could not or would not take standard …
Phase: PHASE2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Pill vs. shot: which blood thinner do bladder cancer patients prefer after surgery?
Disease control CompletedThis trial compared two blood thinners—apixaban (a pill) and enoxaparin (a shot)—in 126 bladder cancer patients after bladder removal surgery. The goal was to see which one patients were more likely to take as prescribed, which they preferred, and what it cost them. Participants …
Phase: NA • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New PTH test could Fine-Tune mineral balance in kidney dialysis
Disease control CompletedThis study looks at whether a new method of measuring parathyroid hormone (PTH) can help doctors better manage calcium and phosphate levels in people on hemodialysis. About 80 patients with end-stage kidney disease will be randomly assigned to have their PTH measured either with …
Phase: NA • Sponsor: Nantes University Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Kidney cancer drugs fail to prevent recurrence after surgery
Disease control CompletedThis large phase 3 trial tested whether taking sorafenib or sunitinib after kidney cancer surgery could prevent the cancer from coming back. Nearly 2000 patients participated. Unfortunately, neither drug improved disease-free survival compared to a placebo, and they caused side e…
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Kidney hope: drug combo may slow alport disease
Disease control CompletedThis completed Phase 4 trial tested two drugs—dapagliflozin and spironolactone—alone and together in 12 adults with Alport syndrome, a genetic kidney disease. The goal was to see if these drugs could lower protein levels in urine, a key sign of kidney damage. Participants took ea…
Phase: PHASE4 • Sponsor: Stefan Lujinschi • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Simple cleaning step may cut infection risk in hysterectomy
Disease control CompletedThis study looks at whether an extra cleaning step before a routine bladder check during laparoscopic hysterectomy can lower the chance of urinary tract infections after surgery. About 98 women having the surgery for non-cancer reasons will be observed. The goal is to see if this…
Sponsor: Alaattin Karabulut • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Which kidney stone blaster works best? study compares three top methods.
Disease control CompletedThis study compared three procedures for removing hard kidney stones that are not in the lower part of the kidney: flexible ureteroscopy (FURS), shock wave lithotripsy (ESWL), and mini-percutaneous nephrolithotomy (Mini-PCNL). 300 adults with a single stone up to 2 cm were random…
Phase: NA • Sponsor: Kafrelsheikh University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Can stem cells from urine help kidneys? small trial tests safety
Disease control CompletedThis early-phase study tested whether stem cells taken from a patient's own urine (called KDSTEM Inj.) are safe for people with chronic kidney disease. Six participants received low or high doses of the cells through an IV. The main goal was to check for side effects, while also …
Phase: PHASE1 • Sponsor: EHL Bio Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug combo takes on advanced cancers in early trial
Disease control CompletedThis early-phase trial tested an experimental drug called KVA12123, given alone or with the immunotherapy Keytruda, in 40 adults with advanced solid tumors (like lung, breast, or colon cancer) that had stopped responding to standard treatments. The main goals were to check safety…
Phase: PHASE1, PHASE2 • Sponsor: Kineta Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Baking soda may cut kidney risk in type 1 diabetes
Disease control CompletedThis study tested whether taking two doses of sodium bicarbonate (baking soda) over 24 hours could reduce uric acid crystals in the urine of adults with type 1 diabetes. Uric acid crystals can harm the kidneys, so lowering them might help prevent diabetic kidney disease. The tria…
Phase: PHASE4 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Cancer-Killing virus plus immunotherapy shows promise in kidney cancer trial
Disease control CompletedThis study tested a combination of two experimental treatments for people with advanced kidney cancer that cannot be removed by surgery. The first is Pexa-Vec, a modified virus designed to infect and destroy cancer cells while also boosting the immune system. The second is cemipl…
Phase: PHASE1, PHASE2 • Sponsor: SillaJen, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could an arthritis drug boost bladder cancer chemo?
Disease control CompletedThis pilot study tested whether adding the anti-inflammatory drug celecoxib (Celebrex) to standard chemotherapy before bladder cancer surgery is safe and affects tumor genes. 22 people with muscle-invasive bladder cancer took part. The goal was to see how the treatment changed ca…
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
6-Year study examines whether a simple strip can keep stress incontinence under control
Disease control CompletedThis study evaluates the long-term safety and effectiveness of Advantage® strips, a type of surgical tape, for treating stress urinary incontinence in women. Researchers are reviewing the medical records of 500 women who received the strip between 2012 and 2015, with an average f…
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug combo shows promise in early cancer trial
Disease control CompletedThis early-phase trial tested a new drug called RO7496353 combined with an immunotherapy (atezolizumab) and sometimes chemotherapy in 102 people with advanced lung, stomach, or pancreatic cancer. The main goal was to check safety and side effects. Researchers also looked at how t…
Phase: PHASE1 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Real-World data shows promise for kidney cancer drug combo
Disease control CompletedThis completed study looked at how well avelumab (BAVENCIO) plus axitinib (INLYTA) works for advanced kidney cancer in everyday medical practice. Researchers tracked 105 patients across multiple EU countries to see survival rates at 12 and 24 months. The goal was to understand th…
Sponsor: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug shows promise for kidney disease in early trial
Disease control CompletedThis study tested a new drug called BION-1301 in 103 healthy volunteers and adults with IgA nephropathy, a kidney disease. The main goal was to check the drug's safety and how the body processes it. Researchers measured side effects, blood pressure, and kidney function over time.
Phase: PHASE1, PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New registry tracks artificial sphincter success for female incontinence
Disease control CompletedThis registry follows 180 women receiving an artificial urinary sphincter for stress incontinence caused by a weak sphincter. Researchers measure how many become dry (using no pads or just one light pad) and how long that dryness lasts over 5 years. Participants also report on se…
Sponsor: European Association of Urology Research Foundation • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Kidney alert team may cut deaths in hospital patients
Disease control CompletedThis study tested whether quickly alerting a kidney specialist team when hospitalized patients show signs of severe kidney disease could improve survival. Over 1,100 patients in France were included. The team of a nephrologist and pharmacist would help manage care during the hosp…
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New dialyser aims to cut blood thinner risks for kidney patients
Disease control CompletedThis study compares two dialysis filters, SOLACEA-H and HYDROLINK-NVU, to see if SOLACEA-H can allow dialysis sessions with less or no blood thinner (heparin). The trial involves 20 adults who have been on dialysis for at least 3 months and are medically stable. Each participant …
Phase: NA • Sponsor: GCS Ramsay Santé pour l'Enseignement et la Recherche • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug combo shows promise for tough bladder cancer
Disease control CompletedThis early-phase trial tested two drugs—durvalumab and vicineum—in 15 people with high-grade non-muscle-invasive bladder cancer that had not responded to standard BCG treatment. The goal was to see if the combination is safe and can help the immune system fight the cancer. Partic…
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Baking soda treatment tested for ICU kidney patients
Disease control CompletedThis study tested whether giving sodium bicarbonate (a common substance that neutralizes acid) to critically ill patients with severe metabolic acidosis and moderate-to-severe acute kidney injury could improve survival at 90 days. The trial enrolled 640 adults in the ICU who had …
Phase: NA • Sponsor: University Hospital, Montpellier • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could a Weight-Loss pill also crush kidney stones?
Disease control CompletedThis pilot study tested whether a combination of phentermine and topiramate, two drugs used for weight loss, could help shrink uric acid kidney stones in obese people with type 2 diabetes or pre-diabetes. Nineteen participants were randomly assigned to receive the drug combo or c…
Phase: PHASE2 • Sponsor: University of Florida • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New blood pressure drug shows promise for kidney disease in early trial
Disease control CompletedThis study tested a new drug called BAY3283142 in 75 people with mild to moderate high blood pressure. The drug is designed to relax blood vessels and is being developed for chronic kidney disease. Participants took different doses or a placebo for up to 10 weeks to check for saf…
Phase: PHASE1 • Sponsor: Bayer • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Fruits and veggies may rival medication for kidney health
Disease control CompletedThis completed study tested whether eating more fruits and vegetables or taking sodium bicarbonate (baking soda) tablets can slow the progression of chronic kidney disease and reduce heart risks in people with high blood pressure and kidney damage. 108 non-diabetic adults with st…
Phase: NA • Sponsor: Donald Wesson • Aim: Disease control
Last updated Jun 27, 2026 13:08 UTC
-
Baking soda and veggies tested as cheap kidney protectors
Disease control CompletedThis study tested whether reducing dietary acid with fruits and vegetables or sodium bicarbonate (baking soda) can slow chronic kidney disease in people with high blood pressure. 153 participants were followed for 5 years to measure kidney function and heart risk markers. The goa…
Phase: NA • Sponsor: Donald Wesson • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Could a simple supplement shield kidneys from disease?
Disease control CompletedThis completed study tested whether adding AC-134, a dietary supplement, to a low-protein diet helps protect kidney function in people with chronic kidney disease. Researchers measured kidney function, protein in urine, and waste products in the blood of 100 adults aged 20-90 wit…
Phase: NA • Sponsor: Taichung Veterans General Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Triple immunotherapy cocktail tested in advanced cancers
Disease control CompletedThis early-phase study tested an experimental drug called APX005M added to two standard immunotherapies (nivolumab and ipilimumab) in 26 people with advanced melanoma or kidney cancer who had not received prior immune therapy. The main goals were to check safety and find the best…
Phase: PHASE1 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Exercise after kidney transplant boosts strength and health
Disease control CompletedThis study looked at whether a 24-week exercise program can improve physical fitness, muscle strength, and overall health in people who received a kidney transplant. 345 adults joined the study six months after their transplant. Researchers compared those who exercised with those…
Phase: NA • Sponsor: Hugo de Luca Correa • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New cocktail of three drugs tested for tough bladder cancers
Disease control CompletedThis early-phase trial tested a combination of two chemotherapy drugs (gemcitabine and carboplatin) plus lenalidomide, a drug that blocks blood vessel growth in tumors, in 18 adults with advanced solid tumors, especially urothelial (bladder) cancer. The main goal was to find the …
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Kidney transplant drug showdown: which regimen saves more function?
Disease control CompletedThis study tested two different combinations of immunosuppressant drugs in 88 adults who received a new kidney. The goal was to see which plan better protects kidney function over the short term. All participants took lifelong anti-rejection medication, so this is about managing …
Phase: PHASE3 • Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New IgA nephropathy drug shows early promise in small trial
Disease control CompletedThis study tested a new drug called XH-S003 in 25 adults with IgA nephropathy, a kidney disease. The goal was to see if the drug is safe and can reduce protein in the urine, a sign of kidney damage, after 90 days. Participants had to have a kidney biopsy confirming the disease. T…
Phase: PHASE2 • Sponsor: S-INFINITY Pharmaceuticals Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Dialysis patients learn to lower potassium through diet
Disease control CompletedThis study tested whether face-to-face nutrition education about potassium could help people on maintenance hemodialysis control their potassium levels. Fifty adult patients with high potassium took part. The goal was to reduce complications and improve quality of life.
Phase: NA • Sponsor: Tanta University • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Could a common diabetes drug help kidneys in sepsis?
Disease control CompletedThis study tested whether metformin, a common diabetes drug, is safe and practical to use for treating acute kidney injury caused by sepsis. Researchers gave low-dose metformin to 80 ICU patients with sepsis and kidney injury, monitoring for side effects and feasibility. The goal…
Phase: PHASE2 • Sponsor: Hernando Gomez • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Could a heart pill protect kidneys in new dialysis patients?
Disease control CompletedThis study tested a drug called sacubitril/valsartan (a heart failure medication) in 45 adults who had just started hemodialysis. The goal was to see if it could improve heart function and help preserve any remaining kidney function compared to a placebo. Participants took the dr…
Phase: PHASE2 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Personalized cancer vaccine shows promise in early trial
Disease control CompletedThis early-phase study tested a personalized cancer vaccine (RO7198457) in 273 patients with advanced solid tumors like melanoma, lung, and breast cancer. The vaccine was given alone or with an immunotherapy drug (atezolizumab) to see if it was safe and how the body responded. Th…
Phase: PHASE1 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New hope for rare blood disorder: ravulizumab trial shows promise in china
Disease control CompletedThis completed Phase 3 trial tested ravulizumab in 18 adults in China with paroxysmal nocturnal hemoglobinuria (PNH), a rare blood disorder that destroys red blood cells. The study measured changes in LDH, a marker of red blood cell breakdown, to see if the drug could control the…
Phase: PHASE3 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Can less immunosuppression save kidneys after transplant?
Disease control CompletedThis study looked at whether giving kidney transplant patients a lower dose of the drug cyclosporine could protect their kidney function over time. 208 patients who were at least one year post-transplant and on stable medications took part. The goal was to balance preventing orga…
Phase: PHASE3 • Sponsor: University Hospital, Rouen • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New lupus drug shows promise in early safety trial
Disease control CompletedThis early-stage trial tested a drug called itolizumab (EQ001) in 52 adults with lupus, some of whom also had active kidney inflammation. The main goal was to check safety and find the right dose. Researchers also looked at how the drug behaves in the body and how it affects immu…
Phase: PHASE1 • Sponsor: Biocon Limited • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Gut bacteria transplant shows promise for recurring UTIs
Disease control CompletedThis study tested whether transplanting healthy gut bacteria (washed microbiota transplantation) could help people who get frequent urinary tract infections (UTIs). Thirty adults with recurrent UTIs received the treatment through a tube into the gut. Researchers tracked how many …
Phase: PHASE1, PHASE2 • Sponsor: The Second Hospital of Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New hope for PNH patients: Long-Term drug safety confirmed
Disease control CompletedThis study tested the long-term safety of a drug called pegcetacoplan in people with PNH, a rare blood disease that destroys red blood cells. All 137 participants had already completed a prior pegcetacoplan study and continued treatment. The main goal was to track side effects ov…
Phase: PHASE3 • Sponsor: Apellis Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New dialysis technique may help critically ill patients stay stable
Disease control CompletedThis study looked at 120 critically ill patients with acute kidney injury and shock who needed dialysis. Researchers compared a special method called sodium profiling dialysis to standard dialysis to see if it helped keep blood pressure stable and reduced fluid buildup in the lun…
Sponsor: Fayoum University • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New drug combo may beat BK virus in kidney transplants
Disease control CompletedThis study tested whether switching from one immunosuppressant to everolimus, along with lowering overall immunosuppression, helps clear BK virus better than just lowering immunosuppression alone. The trial involved 130 kidney transplant recipients with BK virus in their blood. T…
Phase: PHASE4 • Sponsor: University Hospital, Strasbourg, France • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New pill shows promise for Tough-to-Treat blood pressure in kidney patients
Disease control CompletedThis phase 2 trial tested whether adding the experimental drug lorundrostat to standard SGLT2 inhibitor therapy can lower blood pressure in adults with chronic kidney disease and albuminuria (protein in urine). Sixty participants received either lorundrostat or a placebo for four…
Phase: PHASE2 • Sponsor: Mineralys Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New device for dialysis access shows promise in 142 patients
Disease control CompletedThis study looked at how well the Ellipsys Vascular Access System works for creating arteriovenous (AV) fistulas in people with end-stage kidney disease who need dialysis. A total of 142 patients were followed for 12 months to see how long the access stayed open and how safe the …
Phase: NA • Sponsor: Medtronic Endovascular • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New hope for kids with wilms tumor: tailored treatment aims to stop relapse
Disease control CompletedThis phase 3 trial tested how well combination chemotherapy with or without radiation therapy works in 395 children and young adults with newly diagnosed stage III or IV Wilms tumor. The goal was to see if adding radiation could improve the chance of staying cancer-free for 4 yea…
Phase: PHASE3 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Curcumin drink may ease inflammation in kidney dialysis patients
Disease control CompletedThis study looked at whether a high-protein drink with added curcumin (a compound from turmeric) could lower inflammation and oxidative stress in adults on hemodialysis for advanced kidney disease. 39 participants were randomly assigned to receive either the curcumin drink or a p…
Phase: PHASE3 • Sponsor: University of Florida • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Gut bacteria study hopes to ease kidney disease
Disease control CompletedThis study tested whether a probiotic supplement could change gut bacteria and reduce harmful antibodies that damage kidneys in IgA nephropathy. 18 adults with the disease took probiotics for 3 months. Researchers measured changes in antibody levels and kidney function to see if …
Phase: NA • Sponsor: University of Leicester • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New hope for kids with rare kidney cancer: chemo first, then surgery to save kidneys
Disease control CompletedThis study tested giving chemotherapy before surgery to children with Wilms tumor, a rare kidney cancer. The goal was to shrink tumors so surgeons could remove less kidney tissue, helping preserve kidney function. 249 children took part, and the approach aimed to reduce the need …
Phase: PHASE3 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Could a herbal tablet protect kidneys in diabetes?
Disease control CompletedThis study tested a plant-based tablet called PH3 in 100 adults with diabetic nephropathy (kidney damage from diabetes). The goal was to see if PH3 can safely reduce protein in the urine, a sign of kidney stress, over 24 weeks. Researchers also looked at the best dose to use in f…
Phase: PHASE2 • Sponsor: PhytoHealth Corporation • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New drug shows promise for kidney disease in early trial
Disease control CompletedThis early-stage study tested a drug called mezagitamab in 17 people with IgA nephropathy, a kidney disease. The main goal was to check for side effects and see how the body processes the drug. Participants received injections under the skin for several weeks and were monitored f…
Phase: PHASE1 • Sponsor: Takeda • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New hope for PNH patients in china: eculizumab shows promise
Disease control CompletedThis study tested eculizumab in 25 adults with PNH in China who had not previously taken complement inhibitors. Participants received infusions over 62 weeks. The main goal was to see if the drug reduced LDH levels, a marker of disease activity. Results showed a decrease in LDH, …
Phase: PHASE3 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New hope for kids with kidney cancer: tailored treatment may reduce side effects
Disease control CompletedThis phase 3 trial studied how well chemotherapy with or without radiation works after surgery for children with a type of kidney cancer called Wilms tumor. Over 800 children with low- or standard-risk disease took part. The goal was to see if less intensive treatment could still…
Phase: PHASE3 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New study tests best strategy to stop kidney stones
Disease control CompletedThis study looked at two different approaches to prevent kidney stones in adults who have had at least two stones in the past five years. One approach used diet and medication based on each person's test results, while the other used a standard one-size-fits-all plan. The goal wa…
Phase: PHASE4 • Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Experimental enzyme shot aims to rescue kidneys in sepsis patients
Disease control CompletedThis study tested a single intravenous dose of TIN816, an enzyme that breaks down ATP to reduce inflammation, in 316 ICU patients with sepsis-related acute kidney injury. The goal was to see if it improves kidney function over 8 days and reduces major kidney problems by day 90. T…
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Real-World data shows promise for kidney cancer drug combo
Disease control CompletedThis study observed 311 adults with advanced kidney cancer who received cabozantinib (a targeted therapy) plus nivolumab (an immunotherapy) as their first treatment. Researchers tracked how long patients lived and how long tumors stayed under control in real-world settings. The g…
Sponsor: Ipsen • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New drug shows promise in advanced bladder cancer battle
Disease control CompletedThis study tested a new drug called sacituzumab govitecan against standard treatments in 711 people with advanced bladder cancer that had spread or couldn't be removed. The goal was to see if the new drug helped people live longer. Participants received either the new drug or a t…
Phase: PHASE3 • Sponsor: Gilead Sciences • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New drug aims to slow kidney disease in IgA nephropathy patients
Disease control CompletedThis Phase 3 trial tested sibeprenlimab, a drug given as a shot under the skin, in 530 adults with IgA nephropathy, a kidney disease. The study compared the drug to a placebo to see if it could reduce protein in the urine and protect kidney function over time. Participants were a…
Phase: PHASE3 • Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New drug shows promise for slowing kidney disease in Non-Diabetic patients
Disease control CompletedThis study tested whether finerenone, a drug that blocks a hormone involved in kidney damage, can reduce protein in urine and slow kidney function decline. One hundred adults with non-diabetic glomerulonephritis took either finerenone or a placebo for 9 months, on top of their us…
Phase: PHASE2 • Sponsor: Alexandria University • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
Can a phone app keep dialysis patients out of the hospital?
Disease control CompletedThis study tested whether a smart app called Weiyin Health could improve follow-up care for 223 adults on peritoneal dialysis for kidney failure. One group used the app for reminders, AI questions, and risk alerts, while the other got standard care via WeChat and phone calls. The…
Phase: NA • Sponsor: The Third Xiangya Hospital of Central South University • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
Bladder cancer drug combo shows promise in major trial
Disease control CompletedThis study tested whether adding the immunotherapy drug pembrolizumab to standard chemotherapy before and after bladder removal surgery helps people with muscle-invasive bladder cancer live longer without the cancer coming back. About 900 participants took part. The goal was to s…
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
Lifestyle coaching may slow kidney disease progression
Disease control CompletedThis study tested a tailored lifestyle counseling program for 120 adults with early-stage chronic kidney disease (CKD). Participants received personalized advice based on their readiness to change, focusing on diet, exercise, and kidney health knowledge. The goal was to see if th…
Phase: NA • Sponsor: National Cheng Kung University • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
New pill shows promise for kidney disease patients
Disease control CompletedThis study tested a new drug called HSK39297 in 87 adults with IgA nephropathy, a kidney disease. The goal was to see if the drug could lower protein levels in urine, a sign of kidney damage, compared to a placebo. Participants took the drug or placebo for up to 24 weeks, and res…
Phase: PHASE2 • Sponsor: Haisco Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
New drug XTX202 tested in patients with advanced cancers
Disease control CompletedThis study tested a new drug called XTX202 in 95 people with advanced solid tumors that had not responded to standard treatments. The goal was to check safety, find the right dose, and see if the drug could shrink tumors. The trial is now complete.
Phase: PHASE1, PHASE2 • Sponsor: Xilio Development, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Tiny study tests supplement to wake up 'dead' kidneys
Disease control CompletedThis completed study tested an oral supplement made from generally recognized as safe (GRAS) ingredients in 8 people with end-stage kidney disease. Two participants had not produced urine for 16 and 22 years. The goal was to see if the supplement could restore even a small amount…
Sponsor: Amar h Zireg • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Immunotherapy duo shows promise in kidney cancer battle
Disease control CompletedThis phase 3 trial compared a combination of two immunotherapy drugs (nivolumab and ipilimumab) against the standard drug sunitinib in over 1,000 people with untreated advanced or metastatic kidney cancer. The study measured how well the tumors shrank, how long patients lived wit…
Phase: PHASE3 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New drug combo tested for tough cancers
Disease control CompletedThis early-stage trial tested a new drug called AZD6244 combined with standard chemotherapies in 140 people with advanced solid tumors (breast, colon, lung, melanoma, kidney). The main goal was to see if the combination is safe and tolerable, and to find the best dose. Researcher…
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New device aims to keep dialysis fistulas working longer
Disease control CompletedThis study tested a device called VasQ that wraps around a surgically created blood vessel connection (fistula) used for dialysis in people with kidney failure. The device is designed to improve blood flow and reduce complications. 144 patients received the device and were follow…
Phase: NA • Sponsor: Laminate Medical Technologies • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New antibiotic combo shows promise against tough UTIs
Disease control CompletedThis study tested a new antibiotic combination, cefepime-zidebactam, against a standard antibiotic (meropenem) in adults hospitalized with complicated urinary tract infections or kidney infections. About 530 participants received either the new drug or the standard one for 7 to 1…
Phase: PHASE3 • Sponsor: Wockhardt • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Experimental shot targets kidney disease at its source
Disease control CompletedThis completed early-stage trial tested an experimental drug called ARO-C3 in 62 healthy volunteers and patients with two types of kidney disease (C3 glomerulopathy and IgA nephropathy). The drug is designed to calm an overactive part of the immune system that can damage the kidn…
Phase: PHASE1, PHASE2 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Bladder cancer trial aims to save organs without sacrificing survival
Disease control CompletedThis study tested a new way to treat muscle-invasive bladder cancer by tailoring therapy based on each patient's tumor genetics. After initial chemotherapy, patients with a good response could avoid bladder removal and instead opt for active monitoring or less invasive treatments…
Phase: PHASE2 • Sponsor: Fox Chase Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New kidney cancer drug shows promise in early trial
Disease control CompletedThis early-stage trial tested a drug called belzutifan in 29 people with advanced clear cell kidney cancer that had worsened after other treatments. The main goal was to check safety and find the right dose. Participants took belzutifan pills daily, and researchers monitored side…
Phase: PHASE1 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New drug duo takes on kidney cancer in major trial
Disease control CompletedThis Phase 3 trial tested whether combining pembrolizumab (an immunotherapy) with epacadostat (a drug that boosts the immune response) works better than standard drugs (sunitinib or pazopanib) for people with advanced kidney cancer that hasn't been treated before. The study enrol…
Phase: PHASE3 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Promising enzyme therapy shows Long-Term safety for rare fabry disease
Disease control CompletedThis study looked at the long-term safety and effectiveness of a drug called pegunigalsidase alfa for adults with Fabry disease, a rare genetic condition. Participants received an infusion every four weeks for up to several years. The goal was to see if the drug is safe over time…
Phase: PHASE3 • Sponsor: Chiesi Farmaceutici S.p.A. • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Could a common heart drug help dialysis patients?
Disease control CompletedThis study tested whether the drug sacubitril/valsartan can improve heart function in people with heart failure who are on chronic hemodialysis. 52 patients were split into two groups: one received the drug, the other standard care. Researchers measured changes in heart ultrasoun…
Phase: PHASE4 • Sponsor: University Clinical Hospital Mostar • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Experimental vaccine trains immune system to attack kidney tumors
Disease control CompletedThis study tested a personalized vaccine made from a patient's own tumor cells fused with immune cells (dendritic cells) to treat stage IV kidney cancer. The vaccine was given with a drug called GM-CSF to boost immune response. The main goal was to check safety and side effects i…
Phase: PHASE1, PHASE2 • Sponsor: Beth Israel Deaconess Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New drug aims to calm immune attack on kidneys
Disease control CompletedThis early-stage trial tested a drug called ARO-CFB in 49 healthy volunteers and people with IgA nephropathy, a kidney disease where the immune system damages the kidneys. The main goal was to check safety and how the drug moves through the body. Participants received either one …
Phase: PHASE1 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New injection aims to tame hormone chaos in kidney dialysis patients
Disease control CompletedThis study tests a new drug called SHR6508 in 303 adults on hemodialysis who have secondary hyperparathyroidism, a condition where parathyroid hormone levels get too high. The drug is given as an injection to help control these hormone levels and related minerals like calcium and…
Phase: PHASE2 • Sponsor: Shanghai Hengrui Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Real-World data shows mepolizumab may keep rare vasculitis in check Long-Term
Disease control CompletedThis study followed 591 adults with eosinophilic granulomatosis with polyangiitis (EGPA) across Europe to see how well mepolizumab 300mg every 4 weeks works over the long term in everyday medical practice. Researchers looked at disease control, lung function, and safety by review…
Sponsor: European EGPA Study Group • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Next-Day clinic aims to cut hospital admissions for common ailments
Disease control CompletedThis study tested a new clinic that sees emergency room patients the next day for conditions like pneumonia, heart failure, and kidney injury. The goal was to avoid hospital stays and improve patient care. About 570 adults took part, and researchers measured how many days they we…
Phase: NA • Sponsor: University of California, Los Angeles • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Could a broccoli supplement slow kidney disease?
Disease control CompletedThis study tested whether a daily supplement called Avmacol Extra Strength, which contains sulforaphane from broccoli seeds, can slow kidney disease progression in people with stage 3 or 4 chronic kidney disease. The trial enrolled 96 adults and compared the supplement to a place…
Phase: PHASE2 • Sponsor: University of Rochester • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Kidney shield? diabetes drug shows promise for teens
Disease control CompletedThis study tested whether a class of diabetes drugs called SGLT2 inhibitors can slow the progression of kidney disease in adolescents with type 1 diabetes. Researchers measured changes in urine protein levels and blood sugar control over 6 months in 86 participants aged 10-18. Th…
Phase: PHASE2, PHASE3 • Sponsor: Ain Shams University • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New stent aims to ease chronic ureter blockages
Disease control CompletedThis study tested a special stent called MEMOKATH 051 in 13 adults with long-term ureter blockages who usually need a standard double J stent. The goal was to see how long the new stent lasts and how well it is tolerated over 3 years. Participants had the new stent placed during …
Phase: PHASE2 • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New drug cocktail aims to fight advanced cancers
Disease control CompletedThis early-phase study tested a daily combination of two oral drugs, axitinib and everolimus, in 19 people with advanced solid tumors, particularly kidney cancer. The main goal was to find the safest dose by monitoring side effects in the first month. Researchers also tracked how…
Phase: PHASE1 • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Anesthesia choice may boost kidney transplant success
Disease control CompletedThis study tested whether using sevoflurane gas for anesthesia during kidney transplant surgery helps the new kidney recover faster than standard propofol anesthesia. 120 adults receiving a kidney transplant were randomly assigned to one of the two anesthetics. Researchers tracke…
Phase: PHASE3 • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New dialysis technique tested for better tolerance in kidney patients
Disease control CompletedThis study compared two types of dialysis in 415 older adults (ages 65-90) with chronic kidney failure: online hemodiafiltration and conventional hemodialysis. The goal was to see which method is better tolerated and whether it reduces heart problems and other complications. Pati…
Phase: PHASE4 • Sponsor: University Hospital, Montpellier • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Drug cuts bleeding risk in kidney stone surgery
Disease control CompletedThis study tested whether giving tranexamic acid, a drug that helps blood clot, through a vein and in surgical fluid can reduce bleeding during kidney stone removal. 90 adults with large kidney stones were randomly assigned to receive the drug or a placebo. The goal was to see if…
Phase: PHASE4 • Sponsor: Benha University • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Lotus seed supplement shows promise for diabetic nerve pain
Disease control CompletedThis completed study tested whether lotus seed capsules could improve nerve health, blood sugar, and immune function in 60 people with type 2 diabetes and nerve damage. Participants took either lotus seed or placebo capsules for 9 months alongside their regular diabetes treatment…
Phase: NA • Sponsor: Riphah International University • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Immune cells may predict CMV relapse in kidney transplant patients
Disease control CompletedThis study looked at 38 kidney transplant patients who had CMV infection. Researchers wanted to see if measuring a type of immune cell (γδ T cells) could help decide who needs extra medication to prevent the virus from coming back. The goal is to avoid unnecessary drugs while sti…
Phase: PHASE2 • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Robot or scalpel? new study tests best bladder cancer surgery
Disease control CompletedThis study compared two types of surgery to remove the bladder in people with bladder cancer: one done with a robot and one done as open surgery. About 339 patients took part across multiple hospitals. The main goal was to see which approach let patients spend more days at home a…
Phase: NA • Sponsor: University College, London • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Grape compound resveratrol tested in teens with diabetic kidney disease
Disease control CompletedThis study tested whether resveratrol, a natural substance found in grapes and peanuts, could improve blood sugar control and kidney health in 60 teenagers with type 1 diabetes and early kidney damage. Participants took resveratrol tablets twice daily for 6 months. The study meas…
Phase: PHASE2, PHASE3 • Sponsor: Ain Shams University • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New drug candidate CBX-12 tested in patients with Hard-to-Treat cancers
Disease control CompletedThis study tested an experimental drug called CBX-12 in 69 adults with advanced solid tumors (like ovarian, lung, breast, or colon cancer) that had stopped responding to standard therapies. The main goals were to check the drug's safety, find the best dose, and see if it could sh…
Phase: PHASE1, PHASE2 • Sponsor: Cybrexa Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New drug shows promise in early trial for rare blood disorder
Disease control CompletedThis early study tested an experimental drug called OMS906 (zaltenibart) in 15 adults with paroxysmal nocturnal hemoglobinuria (PNH), a rare blood disease where red blood cells break apart. The main goal was to check safety and how the body handles the drug. Researchers also look…
Phase: PHASE1 • Sponsor: Omeros Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New monitoring technique may shield kidneys during liver surgery
Disease control CompletedThis study tested a new way to monitor kidney oxygen levels during liver surgery to try to prevent acute kidney injury (AKI). 80 adults having liver surgery were randomly assigned to either standard care or extra monitoring that triggered a step-by-step treatment plan if oxygen l…
Phase: PHASE1 • Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New combo therapy shows promise for Tough-to-Treat kidney cancer
Disease control CompletedThis study tested whether adding an immunotherapy drug (nivolumab) to a targeted therapy (tivozanib) helps people with advanced kidney cancer live longer without their cancer growing. The trial included 343 adults whose cancer had worsened after one or two prior treatments, inclu…
Phase: PHASE3 • Sponsor: AVEO Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New anticoagulation strategy tested for dialysis circuits in ECMO patients
Disease control CompletedThis study tested whether adding regional citrate anticoagulation (RCA) to standard heparin can reduce clotting in continuous kidney dialysis circuits for patients on ECMO. Eighteen ICU adults with ARDS and acute kidney injury were enrolled. Each patient received alternating peri…
Phase: NA • Sponsor: University of Milano Bicocca • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Real-World check: newer PNH drug holds up in routine care
Disease control CompletedThis study followed 120 adults with paroxysmal nocturnal hemoglobinuria (PNH) who switched from the older drug eculizumab to the newer ravulizumab. Researchers measured changes in a blood marker called LDH to see if the new drug controlled red blood cell breakdown just as well or…
Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New blood filter may boost survival in septic shock patients on dialysis
Disease control CompletedThis study looked back at 400 critically ill patients with septic shock and kidney failure who needed dialysis. Researchers compared those who received a special filter (Oxiris) that removes toxins and inflammation-causing substances to those who got standard filters. The goal wa…
Sponsor: Clinica Universidad de Navarra, Universidad de Navarra • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Dialysis fluid shows promise in slowing artery hardening
Disease control CompletedThis study looked at whether adding citrate to the fluid used during dialysis can slow the buildup of calcium in blood vessels. 54 adults on hemodialysis who already had some vessel hardening took part. Each person used a standard fluid for 12 months and a citrate fluid for anoth…
Phase: NA • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New drug aims to tame inflammation in kidney patients
Disease control CompletedThis study tested an experimental drug, ziltivekimab, in 36 adults with advanced chronic kidney disease (not on dialysis) to see if it can safely reduce inflammation and related heart risks. Participants received either a low dose, a high dose, or a placebo injection every 4 week…
Phase: PHASE2 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Breakthrough drug may give hope to kidney patients rejected for transplant
Disease control CompletedThis study tested a drug called imlifidase in 113 highly sensitized kidney patients who had a positive crossmatch against a deceased donor. The drug was given before transplant to reduce the risk of rejection. The main goal was to see how many patients still had a working kidney …
Phase: PHASE3 • Sponsor: Hansa Biopharma AB • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Could selenium boost kidney cancer treatment?
Disease control CompletedThis trial tested a combination of two drugs—axitinib (a standard kidney cancer drug) and seleniomethionine (a form of selenium)—in 45 adults with advanced clear cell renal cell carcinoma that had spread. The goal was to find the safest dose and see if the combination could shrin…
Phase: PHASE1, PHASE2 • Sponsor: Mohammed Milhem • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Sound waves smash kidney stones without surgery
Disease control CompletedThis study tested a device called Break Wave™ that uses focused ultrasound waves to break kidney stones into tiny pieces that can pass naturally. 64 adults with upper urinary tract stones (4-10 mm) received the treatment. The goal was to see if the device is safe and effective at…
Phase: NA • Sponsor: SonoMotion • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New drug cocktail aims to improve kidney transplant success
Disease control CompletedThis phase 2 trial tested a new combination of drugs—siplizumab, belatacept, and mycophenolic acid—in 76 people who just received a kidney transplant. The goal was to see if this combo is safer and works better than the usual immunosuppression therapy. Researchers measured side e…
Phase: PHASE2 • Sponsor: ITB-Med LLC • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New cancer drug HBM1020 tested in tiny early trial
Disease control CompletedThis early-phase study tested a new drug, HBM1020, in 17 people with advanced solid tumors that had stopped responding to standard treatments. The main goal was to check safety and find the right dose. The drug was given by IV every three weeks. Because this is a Phase 1 trial, i…
Phase: PHASE1 • Sponsor: Harbour BioMed US, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New antibody VIS649 tested in humans for first time to fight kidney disease
Disease control CompletedThis early-phase trial tested the safety of a new drug called VIS649 in 51 healthy volunteers. VIS649 is an antibody that blocks a protein called APRIL, which is thought to play a role in IgA nephropathy, a kidney disease. The study gave single doses of the drug or a placebo and …
Phase: PHASE1 • Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Zapping kidney nerves may tame tough blood pressure
Disease control CompletedThis study tested a device that uses ultrasound to calm overactive nerves in the kidneys, which can drive high blood pressure. Researchers enrolled 44 people with stage 3 chronic kidney disease and uncontrolled hypertension. Half received the real procedure, half a sham, to see i…
Phase: NA • Sponsor: University of Erlangen-Nürnberg Medical School • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
Breakthrough drug could open door to kidney transplants for 'Impossible' patients
Disease control CompletedThis phase 3 trial tested a drug called imlifidase in 64 highly sensitized kidney transplant patients who had almost no chance of finding a compatible donor. The drug breaks down harmful antibodies, allowing a transplant from a donor that would normally be rejected. The study mea…
Phase: PHASE3 • Sponsor: Hansa Biopharma AB • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Nighttime dialysis matches daytime in cleaning blood, study finds
Disease control CompletedThis study compared two types of home dialysis for people with end-stage kidney disease: nighttime automated dialysis (APD) and daytime manual dialysis (CAPD). 137 non-diabetic adults tried each method for 12 weeks. The goal was to see if nighttime dialysis was as good as daytime…
Phase: NA • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Potassium binder lets heart patients get full drug benefits
Disease control CompletedThis study tested whether a drug called Lokelma (SZC) can help people with both chronic kidney disease and heart failure safely reach higher doses of life-saving heart medications (RAAS inhibitors) without dangerous potassium spikes. 112 adults with stable kidney disease and hear…
Phase: PHASE3 • Sponsor: St George's, University of London • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Exercise and diet may slow early kidney damage
Disease control CompletedThis study looked at whether a 12-week program of exercise, a protein-controlled diet, and education could improve health in people with early-stage kidney disease (stages G1 and G2). Fifteen participants completed the program. Researchers measured changes in cholesterol, muscle …
Phase: NA • Sponsor: University of Guadalajara • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New device aims to suck out kidney stones more safely
Disease control CompletedThis study tested a new tool called the CVAC System, a steerable catheter that helps remove kidney stones during a procedure called ureteroscopy. Thirty adults with kidney stones took part. The main goal was to see how safe the device is and how well it clears stones, measured by…
Phase: NA • Sponsor: Calyxo, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Vitamin B6 shows promise for diabetes blood vessel health
Disease control CompletedThis study tested whether a form of vitamin B6 called pyridoxamine can improve the health of small blood vessels in people with type 2 diabetes. The researchers gave 40 participants either pyridoxamine or a placebo for a period, then switched treatments to compare effects. They m…
Phase: NA • Sponsor: Maastricht University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New antibody drug shows promise for kidney disease
Disease control CompletedThis Phase 2 trial tested a drug called felzartamab in 54 adults with IgA nephropathy, a kidney disease that can lead to kidney failure. The drug targets immune cells to reduce protein leakage in urine, a sign of kidney damage. The study compared felzartamab to a placebo to see i…
Phase: PHASE2 • Sponsor: HI-Bio, A Biogen Company • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New drink flavors aim to help kidney patients stay nourished
Disease control CompletedThis study tested two flavors of a high-energy, low-protein drink called Renalive® LP in 74 adults with chronic kidney disease stages 3b-5. Participants drank the formula as a meal replacement or supplement for 4 weeks. The goal was to see if the drink was suitable and helped mai…
Phase: NA • Sponsor: Fresenius Kabi Taiwan Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Lab-Grown collagen patch may replace mouth tissue for urethra repair
Disease control CompletedThis pilot study tested a bioengineered collagen scaffold as a substitute for the traditional mouth-tissue graft used in urethral stricture repair. Five adult men with a short urethral stricture (less than 3 cm) received the implant. The main goal was to see if the urethra stayed…
Phase: NA • Sponsor: Regenosca SA • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Immunotherapy combo may delay progression in advanced bladder cancer
Disease control CompletedThis study tested whether a combination of two immunotherapy drugs (nivolumab and ipilimumab) could help keep advanced bladder cancer from growing after initial chemotherapy. It involved 25 adults whose cancer had not worsened after first-line chemo. The goal was to see if this m…
Phase: PHASE2 • Sponsor: Spanish Oncology Genito-Urinary Group • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Prebiotic fiber and exercise may ease inflammation in kidney patients
Disease control CompletedThis study looked at whether taking a prebiotic fiber (resistant starch) and doing moderate aerobic exercise for 16 weeks could reduce inflammation and improve blood vessel health, thinking, and mood in people with stage 3-4 chronic kidney disease. 68 patients were randomly assig…
Phase: NA • Sponsor: Springfield College • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Plant-Based diet and exercise may boost mobility in kidney patients
Disease control CompletedThis study tested whether a 6-month program of plant-based diet, home exercise, medication management, and behavioral counseling could improve physical function in 42 adults with stage 3-4 chronic kidney disease. Participants were randomly assigned to the lifestyle program or usu…
Phase: NA • Sponsor: Springfield College • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New radiation therapy shows promise for Tough-to-Treat kidney cancer
Disease control CompletedThis study tested a new treatment for people with advanced clear cell kidney cancer that had spread and stopped responding to standard therapies. Six adults received four injections of a radioactive drug (177Lu-PSMA-1) that targets cancer cells. The goal was to check safety and s…
Phase: PHASE1, PHASE2 • Sponsor: Centre Leon Berard • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New drug shows promise for kidney disease in phase 2 trial
Disease control CompletedThis study tested a new drug called VIS649 in 155 adults with IgA nephropathy, a kidney disease. The goal was to see if the drug is safe and can reduce protein in the urine, a sign of kidney damage. Participants received either the drug or a placebo, and researchers monitored sid…
Phase: PHASE2 • Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Could a common arthritis drug help black patients with kidney disease?
Disease control CompletedThis study tested whether baricitinib, a drug used for arthritis, can safely reduce high protein levels in the urine of African American adults with a specific genetic form of kidney disease (APOL1). Eight participants took the drug to see if it lowered their urine protein and pr…
Phase: PHASE2 • Sponsor: Duke University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New drug aims to stop kidney disease from coming back after transplant
Disease control CompletedThis phase 2 study tested a drug called pegcetacoplan in 13 kidney transplant patients whose original kidney disease (C3G or IC-MPGN) had come back. The goal was to see if the drug could reduce signs of disease activity in the kidney. The study was small and early-stage, so resul…
Phase: PHASE2 • Sponsor: Apellis Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Sticker shock: simple picture boosts antibiotic use in UTI patients
Disease control CompletedThis study tested whether a visual storytelling sticker on antibiotic packaging helps adults with urinary tract infections (UTIs) take all their medicine. 358 adults in Pakistan were randomly assigned to get either the sticker or usual care. The goal was to see if the sticker imp…
Phase: NA • Sponsor: Xi'an Jiaotong University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New drug combo helps High-Risk kidney cancer patients avoid full kidney removal
Disease control CompletedThis study tested a combination of two drugs (cadonilimab and lenvatinib) given before surgery to 39 people with kidney cancer that was difficult to operate on while saving the kidney. The goal was to shrink the tumor enough to allow a partial, kidney-sparing surgery instead of r…
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New hope for kidney patients: experimental anemia drug shows promise
Disease control CompletedThis study tested a new drug called DISC-0974 in 55 adults with chronic kidney disease (not on dialysis) who also have anemia. The goal was to check the drug's safety and how the body processes it. Participants received either the drug or a placebo by injection. The results will …
Phase: PHASE1 • Sponsor: Disc Medicine, Inc • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New kidney drug shows promise in FSGS trial
Disease control CompletedThis Phase 3 trial tested whether sparsentan, a drug that blocks two pathways involved in kidney damage, can better protect kidney function than the standard treatment irbesartan in people with focal segmental glomerulosclerosis (FSGS). The study enrolled 371 adults and children …
Phase: PHASE3 • Sponsor: Travere Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
New daily pill could rival insulin for diabetes and heart risk
Disease control CompletedThis study tested a once-daily pill called orforglipron against insulin glargine in nearly 2,750 adults with type 2 diabetes, obesity or overweight, and increased cardiovascular risk. The main goal was to see if orforglipron could reduce major heart events like heart attacks or s…
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
Blue dye may keep blood pressure up during kidney dialysis
Disease control CompletedThis study tested whether methylene blue, a dye that affects blood vessel function, can prevent dangerous drops in blood pressure during kidney dialysis. It involved 261 critically ill adults with acute kidney injury who needed dialysis. The goal was to see if the treatment could…
Phase: PHASE2 • Sponsor: Federal University of São Paulo • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Which IV fluid is best after a kidney transplant? new study has answers
Disease control CompletedThis study compared two types of IV fluids given to kidney transplant patients during their first week after surgery. The goal was to see which fluid better prevents electrolyte imbalances and helps the new kidney work well. About 159 adult patients who received a kidney from a l…
Phase: PHASE3 • Sponsor: King Chulalongkorn Memorial Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Immunotherapy combo before kidney surgery shows promise in small trial
Disease control CompletedThis early-phase study tested two immunotherapy drugs (spartalizumab and canakinumab) given before surgery to 17 people with localized clear cell kidney cancer. The main goal was to see if this approach was safe and did not delay surgery. The study also looked at how the drugs af…
Phase: EARLY_PHASE1 • Sponsor: Columbia University • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Natural supplement aims to stop painful kidney stones
Disease control CompletedThis study tests whether taking a daily alpha lipoic acid supplement can reduce the return of cystine kidney stones in people with cystinuria. Half of the 50 participants will take 1200 mg of the supplement daily for three years, and the other half will take a placebo. The main g…
Phase: PHASE2 • Sponsor: Thomas Chi, MD • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Drug shows promise for kidney cancer brain metastases in early trial
Disease control CompletedThis phase 2 trial tested the drug sunitinib in 21 patients with kidney cancer that had spread to the brain. The goal was to see if the drug could shrink brain tumors by blocking blood flow and cell growth. Researchers measured how many patients had a response after two treatment…
Phase: PHASE2 • Sponsor: Institut Claudius Regaud • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Free fruits and veggies may boost kidney health in Food-Insecure patients
Disease control CompletedThis pilot study tested whether giving produce vouchers to 100 adults with chronic kidney disease and food insecurity could improve their health. Participants received $40-$60 in vouchers every two weeks for six months. Researchers measured changes in food security, diet quality,…
Phase: NA • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Gut health boost may ease dialysis burden
Disease control CompletedThis study tested whether taking probiotics or synbiotics (probiotics plus fiber) for 6 months could improve health in 60 adults with kidney failure on dialysis. Researchers measured changes in blood toxins, heart health, quality of life, and thinking ability. The goal was to see…
Phase: NA • Sponsor: Mansoura University • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New dialysis fluid shows promise for kidney patients in Real-World test
Disease control CompletedThis study tested a special dialysis fluid called icodextrin in 439 adults with chronic kidney failure who use peritoneal dialysis at home. The goal was to see if it works better than standard glucose solutions for overnight exchanges and to check for side effects. Researchers tr…
Sponsor: Vantive Health LLC • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New tacrolimus tablet tested in kidney transplant patients
Disease control CompletedThis study looked at how a tacrolimus tablet (TacroBell) works in people who received a kidney transplant. The goal was to measure drug levels in the blood and see how well patients tolerated it. 128 adults who were getting a kidney from a deceased or living donor took part. The …
Phase: PHASE4 • Sponsor: Chong Kun Dang Pharmaceutical • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New laser technique may improve bladder cancer surgery outcomes
Disease control CompletedThis study compared two surgical techniques for removing early-stage bladder tumors: a new laser method (holmium laser en-bloc resection) and the standard approach (conventional transurethral resection). 100 adults with suspected non-muscle-invasive bladder cancer were randomly a…
Phase: NA • Sponsor: Beni-Suef University • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Bladder bacteria transplant shows promise for painful condition
Disease control CompletedThis phase 1 trial tested a new treatment called urinary microbiota transplantation (UMT) for people with cystitis glandularis, a chronic bladder condition often linked to pelvic lipomatosis. The treatment involves placing processed donor urine bacteria into the bladder. After on…
Phase: PHASE1 • Sponsor: Peking University First Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Copper-Coated catheter aims to slash hospital infections
Disease control CompletedThis study tested a new type of urinary catheter coated with copper nanoparticles to see if it could lower the risk of urinary tract infections in hospitalized adults. 256 patients who needed a catheter for a long time took part. The goal was to compare this new catheter to stand…
Phase: NA • Sponsor: WMAS SpA • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Simple blood or urine test could spot kidney cancer early
Diagnosis CompletedThis study collects blood, tissue, and urine from about 589 people with different types of kidney or urinary tract tumors, plus healthy volunteers. Researchers are looking for special DNA markers (methylated DNA) that could help detect these cancers earlier and more accurately. T…
Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Jul 03, 2026 00:00 UTC
-
AI model could spare diabetes patients from invasive kidney biopsies
Diagnosis CompletedThis study uses machine learning to tell apart diabetic kidney disease from other kidney diseases in people with type 2 diabetes. Researchers analyzed data from over 2,200 patients across 14 medical centers to build a model that uses routine clinical and lab information. The goal…
Sponsor: Beijing Tongren Hospital • Aim: Diagnosis
Last updated Jul 01, 2026 00:00 UTC
-
Urine test may predict kidney recovery in septic shock patients
Diagnosis CompletedThis study tested whether a urine test measuring two proteins (TIMP2 and IGFBP7) can tell which septic shock patients will recover normal kidney function within 72 hours. Researchers analyzed data from 77 patients in French ICUs. The goal is to help doctors decide who needs aggre…
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Diagnosis
Last updated Jun 27, 2026 14:02 UTC
-
New scan could sharpen bladder cancer staging
Diagnosis CompletedThis pilot study tested whether a new radioactive tracer called 18F-fluciclovine, used with a PET/CT scan, can better determine the extent of muscle invasive bladder cancer before surgery. Sixteen participants with bladder cancer received the tracer and scan before their planned …
Phase: EARLY_PHASE1 • Sponsor: Brigham and Women's Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 14:02 UTC
-
MRI may spare babies radiation in kidney blockage diagnosis
Diagnosis CompletedThis study looked at whether functional MRI can accurately measure kidney function in children with pyelo-ureteral junction syndrome, a common urinary blockage. Researchers compared MRI results to the standard scintigraphy scan in 270 children aged 0-17. The goal was to see if MR…
Sponsor: Central Hospital, Nancy, France • Aim: Diagnosis
Last updated Jun 27, 2026 14:00 UTC
-
AI-Powered Ultra-Low radiation CT could revolutionize kidney stone diagnosis
Diagnosis CompletedThis study tested whether an ultra-low-dose CT scan, combined with a deep-learning AI reconstruction, can accurately detect urinary tract stones. 62 adults with known or suspected kidney stones received both a standard low-dose CT and an additional ultra-low-dose scan (less than …
Phase: NA • Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Diagnosis
Last updated Jun 27, 2026 14:00 UTC
-
New urine test may spot kidney danger before it strikes
Diagnosis CompletedThis study tested a new urine test (RENISCHEM L-FABP) to see if it can predict acute kidney injury within 2 days after heart or blood vessel procedures that use contrast dye. Researchers measured a kidney stress marker in 382 adults at higher risk. The goal was to validate the te…
Sponsor: Hikari Dx, Inc. • Aim: Diagnosis
Last updated Jun 27, 2026 13:08 UTC
-
Could a simple breath test spot hidden diseases early?
Diagnosis CompletedThis study is testing a portable, non-invasive breath analyzer that measures tiny particles in exhaled breath to screen for conditions like type 2 diabetes, liver disease, kidney disease, and lung disease. Researchers will enroll healthy volunteers and people with known diagnoses…
Sponsor: Respyr • Aim: Diagnosis
Last updated Jun 27, 2026 13:07 UTC
-
New device may predict kidney recovery in ICU patients
Diagnosis CompletedThis study tested whether the Nephrocheck™ device can predict if early acute kidney injury will reverse within 72 hours in patients with septic shock. Researchers enrolled 184 adults in the ICU and measured the device's accuracy. The goal is to help doctors decide who might recov…
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Diagnosis
Last updated Jun 27, 2026 13:06 UTC
-
New urine test could spot bladder cancer without a scope
Diagnosis CompletedThis study tested whether analyzing urine with a special light technique (spectroscopy) can accurately detect bladder cancer. Researchers collected urine samples from 899 people undergoing cystoscopy. The goal was to see if the light patterns could tell apart those with cancer fr…
Sponsor: CHU de Reims • Aim: Diagnosis
Last updated Jun 27, 2026 13:05 UTC
-
Can a special MRI spot kidney cancer better?
Diagnosis CompletedThis study tested whether a special type of MRI, called perfusion MRI, can help doctors find and diagnose kidney tumors more accurately. 75 people with kidney cancer or suspected kidney tumors took part. The goal was to see if this imaging method could predict tumor type and how …
Phase: NA • Sponsor: Rutgers, The State University of New Jersey • Aim: Diagnosis
Last updated Jun 27, 2026 13:01 UTC
-
Simple ultrasound test may spot kidney risk in preeclampsia patients
Diagnosis CompletedThis study tested whether a special ultrasound score (called VEXUS) can predict acute kidney injury in women with severe preeclampsia when they are admitted to the hospital. Researchers examined 70 women using Doppler ultrasound to check blood flow in key veins. The goal was to s…
Sponsor: Cairo University • Aim: Diagnosis
Last updated Jun 27, 2026 13:00 UTC
-
AI and PET scans join forces to grade cancer without a biopsy
Diagnosis CompletedThis completed study tested whether combining PET/MRI scans with machine learning could better assess how aggressive prostate cancer and other solid tumors are. Researchers enrolled 50 adults with prostate cancer, liver cancer, brain tumors, or kidney cancer. The goal was to see …
Sponsor: Ciprian Catana, MD, PhD • Aim: Diagnosis
Last updated Jun 27, 2026 12:37 UTC
-
New MRI method could spare thousands from unnecessary kidney surgery
Diagnosis CompletedThis completed study tested whether a special type of MRI (multiparametric MRI) can accurately tell the difference between benign and malignant small kidney tumors. About 387 adults with small solid kidney masses (1.5-4 cm) were scanned before surgery or biopsy. The goal was to s…
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Diagnosis
Last updated Jun 27, 2026 12:32 UTC
-
New MRI method shows promise for spotting aggressive bladder cancer
Diagnosis CompletedThis study tested how well a special MRI scan (called multiparametric MRI) can tell if bladder cancer has grown into the muscle layer of the bladder. Researchers used a scoring system called VI-RADS to interpret the scans. The study included 60 people with bladder masses who were…
Sponsor: Ain Shams University • Aim: Diagnosis
Last updated Jun 27, 2026 12:32 UTC
-
New questionnaire could help millions avoid kidney failure
Diagnosis CompletedThis study tested a short questionnaire called SCORED to see if it can accurately identify adults in Asia who are at risk for chronic kidney disease (CKD). Over 1,400 people took part across multiple hospitals. Researchers measured how well the questionnaire predicted kidney prob…
Sponsor: AstraZeneca • Aim: Diagnosis
Last updated Jun 27, 2026 12:32 UTC
-
Light sensor may spot kidney danger during heart surgery
Diagnosis CompletedThis study looked at whether a special light-based monitor (near-infrared spectroscopy) placed on the skin can help predict kidney injury after heart surgery. Researchers measured oxygen levels in the kidneys of 113 adults during surgery and checked if low levels were linked to l…
Sponsor: SERAY TÜRKMEN • Aim: Diagnosis
Last updated Jun 27, 2026 12:31 UTC
-
Breath sniffing device may predict cancer drug success
Diagnosis CompletedThis study tested whether a simple breath test can predict if cancer patients will respond to immunotherapy drugs. Researchers used an electronic nose device to analyze breath samples from 190 patients with lung, melanoma, kidney, bladder, or head and neck cancers. The goal is to…
Sponsor: University Health Network, Toronto • Aim: Diagnosis
Last updated Jun 27, 2026 12:30 UTC
-
New scan could spot kidney damage from diabetes earlier
Diagnosis CompletedThis early-phase trial tested a radioactive tracer called Tc-99m-Tilmanocept to see if it can help doctors detect diabetic kidney disease using SPECT/CT scans. The study involved 57 adults with suspected diabetic kidney disease. The goal was to measure how the tracer behaves in t…
Phase: PHASE1 • Sponsor: University of California, San Diego • Aim: Diagnosis
Last updated Jun 27, 2026 12:29 UTC
-
Urine test could spot bladder cancer without a scope
Diagnosis CompletedThis study looked at whether a urine test called Cxbladder can accurately detect bladder cancer in 682 people who had blood in their urine. The test's results were compared to the standard method, a camera exam of the bladder (cystoscopy). The goal was to see if the urine test co…
Sponsor: Pacific Edge Limited • Aim: Diagnosis
Last updated Jun 27, 2026 12:23 UTC
-
Could a probiotic plus smart antibiotic use end the cycle of recurrent UTIs in children?
Prevention CompletedThis early-phase trial tests whether taking a daily probiotic (Saccharomyces boulardii) and using a targeted antibiotic (ciprofloxacin) only when a UTI occurs can reduce the number of repeat infections in children aged 2 to 17. Participants have had at least three UTIs in the pas…
Phase: EARLY_PHASE1 • Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago • Aim: Prevention
Last updated Jul 03, 2026 00:00 UTC
-
Touch training may stop pregnancy bladder leaks
Prevention CompletedThis study tested whether adding tactile (touch) feedback to pelvic floor muscle training helps prevent stress urinary incontinence in pregnant women. 141 women in their third trimester were assigned to routine education, standard pelvic floor exercises, or exercises with hands-o…
Phase: NA • Sponsor: Far Eastern Memorial Hospital • Aim: Prevention
Last updated Jun 27, 2026 14:02 UTC
-
Smart water bottle trial aims to flush away kidney stones
Prevention CompletedThis study tested whether a program to help people drink more water could prevent kidney stones from coming back. Over 1,600 adults and children who had a kidney stone in the past used a smart water bottle to track their intake, with some getting financial rewards for meeting the…
Phase: NA • Sponsor: Duke University • Aim: Prevention
Last updated Jun 27, 2026 14:02 UTC
-
Simple sugar may shield catheter users from painful infections
Prevention CompletedThis study tested whether D-mannose, a natural sugar, can prevent urinary tract infections (UTIs) in people who need a catheter for a long time. Nineteen participants with recurrent UTIs were followed to see if D-mannose reduced the number of infections needing treatment. The goa…
Phase: NA • Sponsor: Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation • Aim: Prevention
Last updated Jun 27, 2026 13:07 UTC
-
Can a simple antibody infusion shield kidney transplants from a sneaky virus?
Prevention CompletedThis study tested whether giving intravenous immunoglobulins (IVIG) could prevent BK virus infection in kidney transplant recipients. The virus often causes graft problems. Researchers enrolled 359 patients with low antibody levels against their donor's virus strain and gave some…
Phase: PHASE4 • Sponsor: University Hospital, Strasbourg, France • Aim: Prevention
Last updated Jun 27, 2026 13:03 UTC
-
Coffee for preemies? study tests caffeine to shield tiny kidneys
Prevention CompletedThis study tested whether giving caffeine early to preterm babies (born before 32 weeks) can prevent acute kidney injury. 236 newborns received either caffeine or standard supportive care within 24 hours of birth. Researchers tracked kidney injury, hospital stay length, and survi…
Phase: NA • Sponsor: Muhammad Aamir Latif • Aim: Prevention
Last updated Jun 27, 2026 12:37 UTC
-
Alcohol lock may stop deadly infections in ICU patients
Prevention CompletedThis study tested a 60% ethanol (alcohol) lock solution to prevent serious catheter infections in 1,460 ICU patients with acute kidney failure needing dialysis. The ethanol lock is placed inside the catheter to kill germs. The goal was to see if it reduces major catheter-related …
Phase: PHASE3 • Sponsor: University Hospital, Clermont-Ferrand • Aim: Prevention
Last updated Jun 27, 2026 12:35 UTC
-
Simple home workouts may help prevent frailty in diabetes and kidney disease patients
Prevention CompletedThis study tested a six-month home-based exercise program using elastic bands to prevent frailty in 120 adults aged 50-85 with type 2 diabetes and chronic kidney disease. The program aimed to improve muscle strength and daily functioning. Researchers measured changes in frailty s…
Phase: NA • Sponsor: University of Alberta • Aim: Prevention
Last updated Jun 27, 2026 12:34 UTC
-
Drug may shield kidneys from dye harm in ICU
Prevention CompletedThis study tested whether pentoxifylline, a drug that improves blood flow, can prevent kidney damage caused by contrast dye used in medical imaging. The trial included 70 adults with chronic kidney disease who were in the intensive care unit and needed contrast dye. Researchers m…
Phase: NA • Sponsor: Tanta University • Aim: Prevention
Last updated Jun 27, 2026 12:28 UTC
-
Can a thymus gland protein shield dialysis patients from COVID-19?
Prevention CompletedThis Phase 2 trial tested whether thymalfasin, a synthetic version of a natural immune-boosting protein, could prevent COVID-19 infection in 189 kidney dialysis patients. These patients are at high risk due to weakened immune systems and frequent clinic visits. The study measured…
Phase: PHASE2 • Sponsor: William B. Ershler, MD • Aim: Prevention
Last updated Jun 27, 2026 12:23 UTC
-
Heart valve drug shows promise in preventing brain and kidney damage
Prevention CompletedThis study tested a drug called conestat alfa in 141 people undergoing a minimally invasive heart valve replacement (TAVI) for severe aortic stenosis. The goal was to see if the drug could reduce the risk of small strokes and kidney damage that can happen after the procedure. Par…
Phase: PHASE2 • Sponsor: University Hospital, Basel, Switzerland • Aim: Prevention
Last updated Jun 27, 2026 12:23 UTC
-
Could a bladder rinse stop UTIs before they start?
Prevention CompletedThis study tested whether putting the antibiotic gentamicin directly into the bladder can prevent recurrent urinary tract infections (UTIs) in postmenopausal women. Twenty women were split into two groups: one received gentamicin via a catheter into the bladder, and the other too…
Phase: PHASE4 • Sponsor: Women and Infants Hospital of Rhode Island • Aim: Prevention
Last updated Jun 27, 2026 12:08 UTC
-
Probiotic cocktail shows promise in battling recurrent UTIs
Prevention CompletedThis study tested whether taking a specific probiotic (Lactobacillus crispatus M247) along with another probiotic blend could help prevent repeat urinary tract infections (UTIs) in women. 84 women with a history of frequent UTIs took either the probiotic combo or a standard probi…
Phase: NA • Sponsor: Liaquat University of Medical & Health Sciences • Aim: Prevention
Last updated Jun 27, 2026 12:08 UTC
-
Ancient needle therapy takes on chronic bladder pain
Symptom relief CompletedThis study investigates whether acupuncture can relieve symptoms and improve quality of life in women diagnosed with treatment-resistant interstitial cystitis/bladder pain syndrome. Participants receive eight sessions of acupuncture over four weeks at specific points on the body.…
Phase: NA • Sponsor: Medipol University • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
New suction tool may speed up kidney stone surgery
Symptom relief CompletedThis study tested a new type of ureteral access sheath with a flexible tip and built-in suction during kidney stone surgery. Fifty adults with kidney stones 10 mm or larger were randomly assigned to receive either the new suction sheath or a standard sheath. The main goal was to …
Phase: NA • Sponsor: Barzilai Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 14:03 UTC
-
Which device works best for leakage? new study seeks answers
Symptom relief CompletedThis study compares two store-bought devices for stress urinary incontinence (leaking urine when coughing, sneezing, or exercising). About 80 women will try both devices over 20 days and report which they prefer. The goal is to see if a web-based study is practical and what facto…
Phase: NA • Sponsor: Vanderbilt University Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
Music and acupressure may soothe dialysis needle pain
Symptom relief CompletedThis study tested whether listening to music and applying acupressure before needle insertion can reduce pain in dialysis patients. 72 participants were split into four groups: music plus acupressure, acupressure alone, music alone, or standard care. Pain was measured during thre…
Phase: NA • Sponsor: Gülsüm Gülşen • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
Could a gentle zap to the neck ease restless legs in dialysis patients?
Symptom relief CompletedThis study tests whether a non-invasive device that sends mild electrical pulses to nerves in the neck can reduce restless legs syndrome in people undergoing dialysis. Thirty-six adults aged 40-50 will receive either real or sham stimulation three times a week for four weeks. Res…
Phase: NA • Sponsor: Cairo University • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
Can pelvic floor training beat pills for bladder leaks in seniors?
Symptom relief CompletedThis study tested whether pelvic floor muscle training, mirabegron, or trospium chloride is better for treating urgency urinary incontinence in women aged 60 and older who are also at high risk of falling. 48 women were randomly assigned to one of three groups and followed for si…
Phase: EARLY_PHASE1 • Sponsor: The University of Texas Medical Branch, Galveston • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
Which painkiller dose works best after kidney stone surgery?
Symptom relief CompletedThis study looked at two different strengths of the numbing medicine bupivacaine used in a nerve block for pain after kidney stone surgery. Sixty adults having the surgery received either a 0.25% or 0.375% concentration. Researchers measured their pain levels, how much extra pain…
Sponsor: Ankara Education and Research Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Cranberry powder may soothe overactive bladder without drugs
Symptom relief CompletedThis study tests whether a daily cranberry extract pill can change the bacteria in the bladder to reduce sudden urges and frequent bathroom trips in women who do not have leakage. Researchers will compare bacteria samples and symptom scores before and after 12 weeks of treatment.…
Phase: PHASE2 • Sponsor: Loyola University • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Holding breath during kidney stone surgery may speed up treatment
Symptom relief CompletedThis study tested whether briefly stopping a patient's breathing during kidney stone laser surgery could make stone removal more efficient by reducing kidney movement. 150 adults with kidney stones were randomly assigned to normal breathing, low-volume breathing, or a short breat…
Phase: NA • Sponsor: Chinese Medical Association • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Music may soothe dialysis discomfort
Symptom relief CompletedThis study tested whether listening to live or recorded music during dialysis can reduce pain, itch, anxiety, and depression. 102 adults on dialysis took part. They had one week of normal dialysis for baseline data, then a week with live music, then a week with recorded music. Re…
Phase: NA • Sponsor: National University of Singapore • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Art therapy eases anxiety for kidney patients on dialysis
Symptom relief CompletedThis study looked at whether art therapy can reduce anxiety and improve mental strength in people with chronic kidney disease who are on hemodialysis. Eighty adults who had been on dialysis for at least six months took part. The results measured changes in anxiety and psychologic…
Phase: NA • Sponsor: EMİNE İNAL • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
Dialysis itch relief: could a simple education program be the answer?
Symptom relief CompletedThis study tested whether a structured education program could help people on dialysis manage chronic itch and improve their quality of life. 104 adults with kidney failure and itch took part, receiving either two educational sessions or standard care. The program focused on unde…
Phase: NA • Sponsor: Ege University • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
New app aims to ease overactive bladder without drugs or surgery
Symptom relief CompletedThis study tested a prescription smartphone app called RiSolve for women with overactive bladder (OAB). The app provides an 8-week program of bladder training, pelvic floor exercises, and digital cognitive behavioral therapy. Researchers enrolled 46 women in Ireland to see if the…
Phase: NA • Sponsor: University of Galway • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC
-
Dialysis patients get a workout boost in new study
Symptom relief CompletedThis study tested whether a combined aerobic and resistance exercise program could improve physical function and muscle health in people receiving peritoneal dialysis. Thirty-six adults on dialysis for at least six months were split into an exercise group and a usual-care group. …
Phase: NA • Sponsor: Dilek GİBYELİ GENEK • Aim: Symptom relief
Last updated Jun 27, 2026 13:04 UTC
-
New dialysis method aims to cut recovery time for kidney patients
Symptom relief CompletedThis pilot study tested an optimized dialysis technique using a special membrane and biofeedback software to see if it helps kidney failure patients recover faster after treatment. 18 patients on standard dialysis who took at least 4 hours to recover were observed. The study meas…
Phase: NA • Sponsor: Ramsay Générale de Santé • Aim: Symptom relief
Last updated Jun 27, 2026 13:02 UTC
-
Smartphone app may ease fear and pain before kidney stone surgery
Symptom relief CompletedThis study tested whether giving patients a mobile app with educational information before kidney stone surgery could reduce their anxiety, fear, pain, and time in the hospital. 68 adults scheduled for surgery were randomly assigned to either receive the app or standard care. Res…
Phase: NA • Sponsor: Tarsus University • Aim: Symptom relief
Last updated Jun 27, 2026 13:02 UTC
-
VR goggles take the sting out of dialysis needles
Symptom relief CompletedThis study tested whether wearing virtual reality goggles during the needle stick for dialysis can lower pain and anxiety. Fifty adults on hemodialysis were randomly assigned to either watch VR content during the procedure or receive usual care. The results will show if a simple,…
Phase: NA • Sponsor: KTO Karatay University • Aim: Symptom relief
Last updated Jun 27, 2026 13:01 UTC
-
New device aims to make dialysis needle sticks easier
Symptom relief CompletedThis study tested a device that uses ultrasound to help guide needles into the blood vessels of people with end-stage kidney disease who need dialysis. Ten adults with an arteriovenous fistula or graft took part. The main goal was to see if the device could help place needles suc…
Phase: NA • Sponsor: X9, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Laughter may be the best medicine for dialysis patients
Symptom relief CompletedThis study looked at whether online laughter therapy could help people on hemodialysis feel less depressed, anxious, and stressed, and improve their quality of life. Sixty-nine adults who were on dialysis took part. They did laughter therapy sessions online. The results showed th…
Phase: NA • Sponsor: Zonguldak Bulent Ecevit University • Aim: Symptom relief
Last updated Jun 27, 2026 12:38 UTC
-
Nurse-Led lessons calm kidney stone patients before shock wave treatment
Symptom relief CompletedThis study tested whether a structured education session led by a nurse could lower anxiety and improve quality of life in 188 adults having their first shock wave lithotripsy for kidney stones. The education covered what to expect during the procedure, pain management, and recov…
Phase: NA • Sponsor: KTO Karatay University • Aim: Symptom relief
Last updated Jun 27, 2026 12:38 UTC
-
New tool helps women with bladder infections skip unnecessary antibiotics
Symptom relief CompletedThis study tested whether a shared decision-making tool could help women with uncomplicated cystitis (bladder infection) and their doctors decide together about antibiotic use. 169 women aged 18-65 participated. The goal was to see if the tool reduced antibiotic use without harmi…
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Symptom relief
Last updated Jun 27, 2026 12:38 UTC
-
Kidney stone showdown: shock waves vs. tiny surgery
Symptom relief CompletedThis study compared two ways to remove kidney stones smaller than 20 mm: shock wave lithotripsy (ESWL) and ultra-mini surgery (PCNL). 138 adults aged 20-60 with a single stone in the kidney pelvis took part. The main goals were to see which method cleared stones better and which …
Phase: NA • Sponsor: Muhammad Aamir Latif • Aim: Symptom relief
Last updated Jun 27, 2026 12:37 UTC
-
Ketamine boosts pain relief for infants after kidney surgery
Symptom relief CompletedThis study looked at 40 infants under 1 year old having kidney surgery. They received a pain block with either bupivacaine alone or bupivacaine plus ketamine. The goal was to see if adding ketamine reduces pain and the need for extra pain medicine after surgery.
Phase: PHASE4 • Sponsor: Alexandria University • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC
-
Time management training may ease fear in kids on dialysis
Symptom relief CompletedThis study tested whether teaching children aged 9-12 how to manage their time during haemodialysis can reduce their anxiety and fear. Twenty children were split into two groups: one received the training, the other got usual care. Researchers measured anxiety and fear levels bef…
Phase: NA • Sponsor: Istanbul University - Cerrahpasa • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC
-
Can a drug shrink nasal polyps in rare disease patients?
Symptom relief CompletedThis study looked at 52 adults with EGPA (a rare inflammatory disease) and severe chronic sinusitis with nasal polyps. They received mepolizumab 300 mg every 4 weeks. The goal was to see if the drug reduces polyp size and improves symptoms like nasal congestion and sense of smell…
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC
-
Salty solution may smash kidney stones better
Symptom relief CompletedThis study tested three different fluids used during shock wave treatment for kidney stones: plain water, normal saline, and saltier water. The goal was to see which fluid breaks stones best with the least pain and skin problems. 294 adults with kidney stones took part.
Phase: NA • Sponsor: Konya City Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC
-
Hand massage eases fatigue and anxiety for kidney patients on dialysis
Symptom relief CompletedThis study tested if hand reflexology massage could reduce fatigue and anxiety in adults with end-stage kidney disease who are on maintenance hemodialysis. 70 patients were split into two groups: one received eight 21-minute hand massage sessions during dialysis over four weeks, …
Phase: NA • Sponsor: Kufa University • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC
-
Sound waves vs. radiation damage: new hope for bladder pain?
Symptom relief CompletedThis completed early-phase trial tested whether low-intensity shockwave therapy (Li-ESWT) can ease symptoms of radiation cystitis, a painful bladder condition from pelvic radiation. Twenty-five adults who had radiation at least six months prior were enrolled. The study compared s…
Phase: EARLY_PHASE1 • Sponsor: Thanakrit Visuthikosol • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC
-
Simple massage and relaxation may soothe dialysis cramps
Symptom relief CompletedThis study tested whether massage and progressive muscle relaxation exercises can reduce the frequency and severity of muscle cramps in people undergoing hemodialysis. 79 patients participated, and the goal was to see if these non-drug approaches offer relief. The findings could …
Phase: NA • Sponsor: University of Yalova • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC
-
Common bladder drug may ease kidney stone surgery
Symptom relief CompletedThis study looked at 131 people having surgery for kidney stones. Some were already taking mirabegron for overactive bladder, which relaxes the ureter. Researchers wanted to see if this helped surgeons insert a tube more easily and caused less injury. The idea is that a relaxed u…
Sponsor: Ankara Training and Research Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:33 UTC
-
Simple stress ball eases pain and anxiety during kidney stone procedure
Symptom relief CompletedThis study tested whether using a stress ball during a non-surgical kidney stone treatment (ESWL) can reduce pain and anxiety. 64 adults having their first ESWL session participated. The stress ball is a simple, cheap tool that distracts the mind. Researchers measured pain, anxie…
Phase: NA • Sponsor: Mersin University • Aim: Symptom relief
Last updated Jun 27, 2026 12:33 UTC
-
Kidney stone showdown: location matters in choosing best surgery
Symptom relief CompletedThis study compared two surgeries—PCNL and RIRS—for removing kidney stones that are 1-2 cm in size. Researchers wanted to see if the stone's location in the kidney affects which surgery works best. 110 adults took part, and the main goal was to see how many people were stone-free…
Phase: NA • Sponsor: Kırıkkale University • Aim: Symptom relief
Last updated Jun 27, 2026 12:33 UTC
-
Can an online wellness program ease anxiety in chronic disease?
Symptom relief CompletedThis study tested a 12-week online mind-body program for adults with chronic conditions like heart failure, cancer, and liver disease. The program included mindful movement, meditation, breathwork, and coping skills. Researchers measured changes in anxiety, depression, fatigue, a…
Phase: NA • Sponsor: University of Alberta • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
New laser may speed up kidney stone removal
Symptom relief CompletedThis study compared two FDA-approved lasers used to break up kidney stones during surgery: the newer SOLTIVE Thulium Fiber Laser and the standard Ho:YAG laser. About 100 adults with a single stone smaller than 2 cm took part. Researchers measured how well each laser cleared stone…
Phase: NA • Sponsor: University of Kansas Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
3D models may speed up kidney surgery
Symptom relief CompletedThis study tested whether using a 3D model of a patient's kidney before surgery could shorten the time needed for robotic-assisted partial nephrectomy (removing a kidney tumor). 370 adults with small kidney tumors took part. The goal was to see if better planning with 3D imaging …
Phase: NA • Sponsor: University of Leipzig • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Pedaling while dialysis: simple exercise may strengthen hearts in kidney patients
Symptom relief CompletedThis study tested whether a 16-week program of cycling during dialysis sessions could improve heart function in 30 adults with kidney failure and early signs of heart stiffness. Participants first received standard care for 16 weeks, then added supervised cycling during dialysis …
Phase: NA • Sponsor: Instituto Nacional de Cardiologia Ignacio Chavez • Aim: Symptom relief
Last updated Jun 27, 2026 12:28 UTC
-
New drug may scratch the itch for dialysis patients
Symptom relief CompletedThis study tested a drug called nemolizumab to see if it can reduce severe itching in adults with chronic kidney disease who are on dialysis. 258 participants received either nemolizumab or a placebo as injections every 4 weeks for 12 weeks. The main goal was to see how many peop…
Phase: PHASE2, PHASE3 • Sponsor: Galderma R&D • Aim: Symptom relief
Last updated Jun 27, 2026 12:28 UTC
-
Could a simple anesthetic shot reduce catheter use after incontinence surgery?
Symptom relief CompletedThis study looked at whether using lidocaine (a numbing drug) instead of saline during sling surgery helps women avoid urinary retention. About 150 women with stress incontinence took part. The goal was to see if fewer women need a catheter after surgery.
Phase: PHASE4 • Sponsor: West Penn Allegheny Health System • Aim: Symptom relief
Last updated Jun 27, 2026 12:26 UTC
-
Kidney stone showdown: which treatment leaves patients happier?
Symptom relief CompletedThis study looked at two methods for removing kidney stones: laser dusting (breaking stones into tiny pieces that pass naturally) and basket extraction (using a small wire basket to remove fragments). Researchers compared how well each method cleared stones, how much pain patient…
Phase: NA • Sponsor: Northwestern University • Aim: Symptom relief
Last updated Jun 27, 2026 12:26 UTC
-
Which nerve block eases kidney surgery pain better?
Symptom relief CompletedThis study compared two types of nerve blocks (ESPB and QLB) for pain control after laparoscopic kidney removal. Sixty-two adults having living-donor nephrectomy received one of the two blocks before surgery. The main goal was to see which block reduced the need for opioid pain m…
Phase: NA • Sponsor: Istanbul Medipol University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:25 UTC
-
App aims to ease bladder leakage in women without surgery
Symptom relief CompletedThis study tested a smartphone app designed to help women with urinary incontinence reduce leakage episodes and improve quality of life. About 194 women used the app or received standard care for 12 weeks. The goal was to see if the app could cut incontinence episodes in half.
Phase: NA • Sponsor: Kranus Health GmbH • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC
-
Squeeze your way to better dialysis: handgrip training boosts fistula success
Symptom relief CompletedThis study tested whether doing handgrip exercises before and after surgery can improve the size and function of dialysis fistulas in people with advanced kidney disease. 40 patients participated, and the main goal was to see if the fistula diameter increased. The approach is sim…
Phase: NA • Sponsor: Hospices Civils de Lyon • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC
-
Dialysis patients: could a workout or arm squeeze shield your heart?
Symptom relief CompletedThis study tested whether light exercise or a technique called remote ischaemic preconditioning (rIPC) — using a blood pressure cuff to briefly restrict blood flow to the arm — could protect the heart during dialysis. 33 adults on hemodialysis took part in three sessions: one wit…
Phase: NA • Sponsor: University of Avignon • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC
-
Simple massage and stretching tested for dialysis cramps
Symptom relief CompletedThis study tested whether a 10-minute vibration massage or static stretching exercise could reduce the severity and duration of muscle cramps that often occur during hemodialysis. Thirty adults with chronic kidney disease on dialysis were randomly assigned to receive vibration ma…
Phase: NA • Sponsor: Figen Akay • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
New pain combo could ease kidney stone recovery
Symptom relief CompletedThis study tested whether adding hyaluronidase to a common numbing drug (bupivacaine) improves pain control after kidney stone surgery. 100 adults undergoing the procedure received an ultrasound-guided nerve block with or without hyaluronidase. The goal was to see if the combinat…
Phase: NA • Sponsor: Kasr El Aini Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Laser zaps away urinary blockages better than Old-School knife?
Symptom relief CompletedThis study compared two ways to treat a narrow urethra (the tube that carries urine out of the body) in 60 men aged 18 to 70. One method uses a laser, the other a cold knife. The goal was to see which works better at improving urine flow after 30 days. The findings could help sta…
Phase: NA • Sponsor: Shahida Islam Medical Complex • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Dialysis patients feel better with Nurse-Led diet and exercise plan
Symptom relief CompletedThis study tested a program led by nurses that combined personalized nutrition advice and supervised exercise for people on hemodialysis. The goal was to see if it could improve their overall quality of life. 120 adults on long-term dialysis took part, with half receiving the pro…
Phase: NA • Sponsor: University of Misan • Aim: Symptom relief
Last updated Jun 27, 2026 12:08 UTC
-
New stent design aims to ease pain after kidney stone removal
Symptom relief CompletedThis study tested a modified Single-J ureteric stent designed to cause less discomfort than the standard Double-J stent after kidney stone surgery. 28 adults who already had a stent placed before surgery received the modified stent during their procedure. Researchers compared sym…
Phase: NA • Sponsor: Austin Health • Aim: Symptom relief
Last updated Jun 27, 2026 12:08 UTC
-
New fixation method speeds up kidney stone removal
Symptom relief CompletedThis study tested a new technique to hold kidney stones in place during a minimally invasive surgery called mini-PCNL. The goal was to make the stone-breaking step faster and reduce leftover fragments. 45 adults with stones smaller than 4 cm took part. The study measured how long…
Phase: NA • Sponsor: Yasser Gamil Elnagar • Aim: Symptom relief
Last updated Jun 27, 2026 12:08 UTC
-
Special drink before surgery may cut complications
Symptom relief CompletedThis early-phase trial tested whether a nutritional supplement called Impact Advanced Recovery® could help men recover better after bladder cancer surgery. Thirty men took the drink before and after their operation. The goal was to see if it reduced surgical complications, infect…
Phase: EARLY_PHASE1 • Sponsor: Jill Hamilton-Reeves, PhD RD LD • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC
-
Can old drugs ease bladder and asthma symptoms in liver disease?
Symptom relief CompletedThis study looked at whether two drugs, mirabegron and montelukast, are safe and helpful for people with liver cirrhosis who also have overactive bladder and asthma. 78 participants took part over 3 months. Researchers tracked bladder symptoms, breathing issues, and side effects …
Phase: PHASE4 • Sponsor: Kafrelsheikh University • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC
-
Foot massage beats sleep training for dialysis patients' rest
Symptom relief CompletedThis study tested two non-drug methods—reflexology (foot massage) and sleep hygiene education—to improve sleep and comfort in 60 adults on hemodialysis. Both approaches helped, but reflexology was more effective. The results suggest a simple, drug-free option for better rest in d…
Phase: NA • Sponsor: Ulfet Kral • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC
-
Cooling dialysis fluid may fight fatigue after treatment
Symptom relief CompletedThis study tested whether lowering the temperature of the dialysis fluid from 36.5°C to 36°C could reduce the tiredness patients often feel after dialysis. Fifty-seven adults on maintenance hemodialysis received three sessions of 'cold dialysis' over one week. Researchers measure…
Phase: NA • Sponsor: Baskent University • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC
-
Sling angle may improve incontinence surgery success
Symptom relief CompletedThis study looked at 184 women with stress urinary incontinence who had a single-incision sling surgery. Researchers compared two sling insertion angles—one acute and one standard—to see which led to better cure rates and quality of life at 6 months. The goal is to find the best …
Sponsor: Shin Kong Wu Ho-Su Memorial Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC
-
No tube, less pain? study tests new kidney stone surgery approach
Symptom relief CompletedThis study compared two ways of doing kidney stone surgery (PCNL). In the standard method, a tube is left in the kidney to drain urine, which can cause pain. In the tubeless method, no tube is placed. Researchers measured pain and painkiller use in 60 adults after surgery. The go…
Phase: NA • Sponsor: Indus Hospital and Health Network • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC
-
Can a culturally smart program close the kidney transplant gap for hispanics?
Knowledge-focused CompletedThis study tests a program designed to increase living donor kidney transplants among Hispanic patients with end-stage renal disease. The program provides Spanish-language education and outreach by bicultural health workers. Researchers will compare transplant rates between Hispa…
Phase: NA • Sponsor: Northwestern University • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Scientists investigate why adrenal tumors produce hormones
Knowledge-focused CompletedThis study looked at adrenal gland tumors to understand why they form, why some release extra hormones, and why some are cancerous. Researchers studied 690 people with known or suspected adrenal tumors. Participants underwent tests like blood draws, imaging scans, and urine colle…
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
New ultrasound technique spots hidden heart trouble in kids on dialysis
Knowledge-focused CompletedThis study tests whether advanced ultrasound techniques (2D and 3D speckle-tracking echocardiography) can detect early signs of heart muscle dysfunction in children aged 4 to 18 with end-stage kidney disease who have been on dialysis for at least a year. Researchers aim to see if…
Sponsor: Al-Azhar University • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Taiwan study checks lupus kidney drug safety
Knowledge-focused CompletedThis study followed 69 people in Taiwan with lupus nephritis who were newly prescribed the drug Myfortic (mycophenolate sodium). Researchers tracked side effects and reasons for stopping the drug over 12 months. The goal was to understand the drug's safety in this specific popula…
Sponsor: Novartis Pharmaceuticals • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Dialysis patients share what they really think about treatment
Knowledge-focused CompletedThis study looked at how dialysis patients personally feel about their treatment. Researchers asked 26 adults with kidney failure to rank 24 statements about their experience. The goal was to better understand their perspectives, not to test a new drug or device.
Sponsor: Yuzuncu Yil University • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Fizzy drink study probes saliva secrets
Knowledge-focused CompletedThis study investigates how flavored carbonated drinks change saliva flow, composition, and taste perception compared to plain water, carbonated water, or non-carbonated drinks. Healthy adults aged 18-45 who regularly drink carbonated beverages will provide saliva samples after t…
Phase: NA • Sponsor: PepsiCo Global R&D • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Sleep drug YZJ-1139 put to the test in kidney patients
Knowledge-focused CompletedThis study examines how the sleep aid YZJ-1139 behaves in people with severe kidney impairment compared to those with normal kidney function. Sixteen adults will receive a single 20 mg dose, and researchers will measure drug levels in the blood and urine, as well as any side effe…
Phase: PHASE1 • Sponsor: Shanghai Haiyan Pharmaceutical Technology Co., Ltd. • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Contrast dye test reveals hidden kidney damage in ICU survivors
Knowledge-focused CompletedThis study uses a dye called iohexol to measure how well the kidneys are working in patients leaving the intensive care unit after acute kidney failure. The goal is to find out how many patients still have reduced kidney function even though their standard blood tests look normal…
Phase: PHASE3 • Sponsor: University Hospital, Angers • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Chocolate tested for kidney effects – but Don't get excited yet
Knowledge-focused CompletedThis study looks at whether eating a single dose of dark chocolate (70% cocoa) changes blood flow to the kidneys and blood pressure, compared to white chocolate. Researchers will use ultrasound to measure kidney blood flow two hours after eating. The study includes 32 people: hea…
Phase: NA • Sponsor: Gregoire Wuerzner; MD • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Kidney function may change how antibiotic levornidazole acts in the body
Knowledge-focused CompletedThis study looks at how a single dose of the antibiotic levornidazole is processed by the body in people with moderate or severe kidney impairment compared to healthy volunteers. Researchers will measure drug levels in the blood and urine, and monitor safety. The goal is to under…
Phase: PHASE1 • Sponsor: Yangtze River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Co. Ltd • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Ankle test may flag kidney danger after heart surgery
Knowledge-focused CompletedThis study looked at 516 patients who had surgery for a torn aorta (aortic dissection). Researchers checked if a high ankle-brachial index (a simple test of blood flow in the legs) before surgery was linked to kidney problems afterward. The goal was to see if this test could help…
Sponsor: Nanjing First Hospital, Nanjing Medical University • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Kidney study reveals how opemalirsen behaves in the body
Knowledge-focused CompletedThis completed study looked at how the drug opemalirsen (AZD2373) is processed in people with different levels of kidney function. Researchers gave a single injection to 35 adults, some with kidney impairment and some with healthy kidneys. The goal was to compare drug levels and …
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Jun 28, 2026 00:00 UTC
-
Tiny heart monitor could uncover why dialysis patients die suddenly
Knowledge-focused CompletedThis study looks at why people on dialysis for kidney failure often have dangerous heart rhythms. Researchers implanted a small heart monitor in 18 patients to track their heartbeats for up to three years. They also used CT scans and ultrasound to see if the dialysis procedure it…
Phase: NA • Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's • Aim: Knowledge-focused
Last updated Jun 28, 2026 00:00 UTC
-
Could your diet trigger kidney stones by changing your immune system?
Knowledge-focused CompletedThis study looked at how eating high or low amounts of oxalate (a natural compound in many foods) affects urine crystals and immune cells in healthy adults. Fourteen participants followed two controlled diets to see if oxalate changes crystal formation and immune function. The go…
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Knowledge-focused
Last updated Jun 28, 2026 00:00 UTC
-
40,000 patients studied: does a simpler cancer drug dose work just as well?
Knowledge-focused CompletedThis completed study looked at 40,000 people with metastatic cancer who received the drug nivolumab. Researchers compared the old way of dosing (based on body weight) with a newer, simpler fixed dose. They used national health data to see if the fixed dose was just as good and mo…
Sponsor: Nantes University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
Nose surgery blood pressure study aims to protect kidneys
Knowledge-focused CompletedThis study looked at 110 adults having nose surgery (septoplasty) to see if different blood pressure targets during surgery affect kidney injury. Patients were split into two groups: one with a lower blood pressure target (50-57 mmHg) and one with a higher target (58-65 mmHg). Ki…
Phase: NA • Sponsor: Fatih Sultan Mehmet Training and Research Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
Ultrasound could help dialysis patients hit the right fluid balance
Knowledge-focused CompletedThis study looked at whether a special ultrasound check (called VExUS) can help doctors set the ideal dry weight for people on hemodialysis. The idea is that by spotting hidden fluid buildup, doctors can safely remove more fluid during dialysis to better control blood pressure. T…
Phase: NA • Sponsor: Fundación Senefro • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
Scientists probe mysterious IgA deposits in kidney disease
Knowledge-focused CompletedThis study looked at the IgA antibodies in 80 people — 40 with IgA nephropathy (a kidney disease) and 40 healthy volunteers. Researchers took one blood sample from each person to analyze the IgA repertoire. The goal was to understand why IgA deposits form in the kidneys, which co…
Sponsor: University Hospital, Limoges • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
Scientists dig into mysterious kidney scarring
Knowledge-focused CompletedThis completed study looked at why some people develop scarring in their kidneys, including rare diseases like FSGS and a mysterious form of chronic kidney disease affecting farm workers. Researchers collected blood, urine, and kidney tissue from 537 participants to better unders…
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
JARDIANCE under the microscope: Real-World safety check for korean kidney patients
Knowledge-focused CompletedThis completed study looked at the safety of the diabetes drug JARDIANCE (empagliflozin) in 299 Korean adults with chronic kidney disease. Researchers tracked side effects and measured changes in a key kidney health marker (urine albumin-creatinine ratio) after 12 and 24 weeks of…
Sponsor: Boehringer Ingelheim • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Simple urine test may predict kidney recovery after acute failure
Knowledge-focused CompletedThis study looked at 287 patients with acute kidney injury caused by tubular necrosis. Researchers measured two substances in urine (PIIINP and NGAL) to see if they could predict whether kidney function would return or if chronic kidney disease would develop. The goal is to find …
Sponsor: Nantes University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Gene test could predict kidney cancer in transplant patients
Knowledge-focused CompletedThis completed study examined whether a specific variation in the VEGF gene (rs699947) is linked to a higher risk of developing kidney cancer in people who have received a kidney transplant. Researchers analyzed DNA from 272 transplant patients, some of whom had kidney cancer. Th…
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Hidden patterns: how three chronic diseases often travel together
Knowledge-focused CompletedThis completed observational study looked at 4500 patients admitted to internal medicine wards with heart failure, COPD, or chronic kidney disease. Researchers aimed to identify which other chronic conditions tend to cluster with these diseases, and how those clusters affect pati…
Sponsor: Fadoi Foundation, Italy • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Pre-Transplant blood test may flag BK virus danger
Knowledge-focused CompletedThis completed study looked at 378 kidney transplant patients to see if measuring antibodies against BK virus before transplant could predict whether the virus would reactivate after surgery. Researchers used a lab-made virus-like particle to test for five different BK virus type…
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
No treatment, just observation: large study looks at PNH blood cells
Knowledge-focused CompletedThis completed study looked at red and white blood cells in people with a rare blood disorder called PNH who also have bone marrow failure. Over 5,500 participants aged 10 and older with aplastic anemia or related conditions provided blood samples. The goal was simply to learn mo…
Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
New tool may predict kidney cancer drug success
Knowledge-focused CompletedThis study tested a prediction tool (nomogram) to see if it could forecast how patients with metastatic clear cell renal cell carcinoma respond to the targeted therapy sunitinib. Researchers looked at 45 patients who had their kidney removed and were treated with sunitinib as the…
Sponsor: Rennes University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
Spinal vs. general anesthesia: which is better for kidney stone surgery?
Knowledge-focused CompletedThis study looked at 90 adults having kidney stone surgery to see if the type of anesthesia—spinal or general—affects the body's inflammation response. Researchers measured blood markers before and after surgery. The goal is to learn which method might lead to less inflammation a…
Sponsor: Elazıg Fethi Sekin Sehir Hastanesi • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
Could adding a second diabetes drug early save lives?
Knowledge-focused CompletedThis study analyzed health records from over 450,000 adults with obesity and type 2 diabetes to see if adding a GLP-1 or SGLT2 drug early improves survival and kidney health. Researchers compared those who added the other drug class within 90 days to those who added a different d…
Sponsor: Chung Shan Medical University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
Where is safer for dialysis catheters: ER or dialysis unit?
Knowledge-focused CompletedThis study looked at 398 adults who needed a temporary dialysis catheter, comparing those who got it in the emergency department versus those who got it in the dialysis unit. Researchers tracked infections and blood clots in the catheter for 10 days after placement. The goal is t…
Sponsor: Antalya Health Sciences University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
Gene hunt for kidney disease FSGS aims to explain racial disparities
Knowledge-focused CompletedThis study searched for genetic factors that may cause focal segmental glomerulosclerosis (FSGS), a kidney disease that can lead to kidney failure. Researchers compared DNA from 616 people, including African-Americans with FSGS, African-Americans with HIV but no FSGS, and non-Afr…
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
New study aims to predict early death risk in elderly kidney patients
Knowledge-focused CompletedThis study follows people over 75 with advanced chronic kidney disease to better understand their health and treatment paths. Researchers want to create a tool that predicts which patients are at high risk of dying soon after starting dialysis. The goal is to help patients, famil…
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
ER wait after admission costs millions, study finds
Knowledge-focused CompletedThis study looked at over 30,000 adults admitted to hospitals in Maryland to understand why some patients wait in the emergency room even after being admitted (called boarding). Researchers wanted to find out what patient traits lead to longer waits, how boarding increases health…
Sponsor: University of Maryland, Baltimore • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Breath test may warn of kidney danger in ICU
Knowledge-focused CompletedThis study looked at 155 critically ill patients on ventilators to see if the difference between carbon dioxide in their breath and blood could predict acute kidney injury. Researchers measured this gap over the first 24 hours in the ICU. The goal was to find a simple, early warn…
Sponsor: Malatya Egitim Ve Arastirma Hastanesi • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Protein clues may predict bladder Cancer's return
Knowledge-focused CompletedThis study looked at whether three proteins (E-cadherin, β-catenin, and SOX4) can help predict if non-muscle invasive bladder cancer will return or get worse after surgery. Researchers examined tissue samples from 30 patients who had bladder tumor removal. The goal was to see if …
Sponsor: Ain Shams University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
UTI superbugs: study reveals resistance patterns in uganda
Knowledge-focused CompletedThis completed study looked at antibiotic resistance in bacteria causing urinary tract infections (UTIs) in Uganda. Researchers compared resistance patterns in patients who sought care at community drug shops versus hospitals. By studying 890 participants, they aim to understand …
Sponsor: St George's, University of London • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Weight loss surgery may shield kidneys in obese patients
Knowledge-focused CompletedThis study looks at whether gastric bypass surgery can protect the kidneys of people who are severely obese and have chronic kidney disease. Researchers measured kidney function before and one year after surgery in 14 patients. The goal is to see if the surgery improves the balan…
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Which tool is faster for inserting a breathing tube? new study compares two devices
Knowledge-focused CompletedThis completed study compared two devices used to place a breathing tube during kidney stone surgery: a videolaryngoscope and a VideoLMA. Researchers measured how long each took and how often they worked on the first try. The trial involved 100 adults and aimed to find which devi…
Phase: NA • Sponsor: Ela Erdem Hıdiroglu • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
New registry aims to unlock secrets of rare kidney cancer
Knowledge-focused CompletedThis completed study created a registry of 28 patients with TFE renal cell carcinoma, a rare kidney cancer. Researchers collected medical data, tumor samples, and images to better understand the disease. The goal is to use this information to guide future research and develop mor…
Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Large study reveals Real-World outcomes of immunotherapy in advanced kidney cancer
Knowledge-focused CompletedThis study reviewed medical records of 494 adults with advanced kidney cancer who received immunotherapy as their first treatment. Researchers looked at how long patients stayed on treatment, how they responded, and survival rates. The goal was to understand which treatment combi…
Sponsor: Pfizer • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
New equation could simplify salt monitoring for kidney dialysis patients
Knowledge-focused CompletedThis study aims to create and test a new mathematical formula that estimates how much sodium (salt) people on peritoneal dialysis consume. The researchers will enroll 30 adults who have been on peritoneal dialysis for at least three months and have no remaining kidney function. I…
Sponsor: Peking University First Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Scientists create new tools to fight rare urinary tract cancer
Knowledge-focused CompletedThis study aimed to create lab models of a rare and aggressive cancer of the upper urinary tract. Researchers took tumor samples from 20 patients and tried to grow them in mice and on chicken egg membranes. The goal was to develop tools to test new treatments for this cancer, whi…
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Study seeks to predict hidden cancer in the ureter after bladder surgery
Knowledge-focused CompletedThis study analyzes data from 748 patients who had their bladder removed due to bladder cancer. The goal is to find factors that can predict whether cancer has spread to the ureter, the tube that carries urine from the kidney to the bladder. By identifying these factors, doctors …
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Kidney cancer patients in Real-World clinics get immunotherapy: does it work?
Knowledge-focused CompletedThis study followed 623 adults in France with advanced kidney cancer who were starting treatment with the immunotherapy drugs nivolumab (with or without ipilimumab) for the first time. Unlike a clinical trial, this was an observational study that simply tracked what happened in e…
Sponsor: Bristol-Myers Squibb • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
ICU antibiotics under scrutiny: new study targets hidden brain risks
Knowledge-focused CompletedThis study followed 400 intensive care patients receiving beta-lactam antibiotics to see how often these drugs cause brain-related side effects like confusion or agitation. Researchers measured antibiotic levels in the blood and checked patients' neurological status several times…
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
NIH study aims to unlock secrets of lung mucus diseases
Knowledge-focused CompletedThis completed study looked at people with genetic conditions that affect how the lungs clear mucus, such as cystic fibrosis and primary ciliary dyskinesia. Researchers examined 87 participants, including healthy volunteers, to understand why these patients get repeated lung infe…
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:08 UTC
-
CBD-Tacrolimus interaction study completed: key dosing insights for transplant recipients
Knowledge-focused CompletedThis study looked at how cannabidiol (CBD) interacts with tacrolimus, a drug used to prevent organ rejection in transplant patients. Researchers wanted to understand how to adjust doses for better health outcomes. The study involved 57 healthy adults and those with chronic kidney…
Phase: PHASE1 • Sponsor: Indiana University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Steroids for kidney disease: do they prevent failure Long-Term?
Knowledge-focused CompletedThis study follows 211 people with IgA nephropathy who previously took a 6-9 month course of the steroid methylprednisolone in the TESTING trial. Researchers want to see if the steroid helped prevent end-stage kidney disease (needing dialysis or a transplant) over the long term. …
Sponsor: The George Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
ICU kidney danger: new study tracks who gets hurt
Knowledge-focused CompletedThis study looked at 174 adults in the intensive care unit (ICU) to find out how often acute kidney injury happens and what factors make it more likely. Researchers tracked patients who stayed in the ICU for at least 48 hours, excluding those with kidney problems at the start. Th…
Sponsor: Haseki Training and Research Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
Second look surgery may spot hidden bladder cancer
Knowledge-focused CompletedThis study tested whether doing a second surgery soon after the first helps manage high-risk non-muscle invasive bladder cancer. 70 patients who had an initial tumor removal got an early second look procedure. The goal was to see if any cancer remained and what factors affected t…
Sponsor: Ain Shams University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
Blood test may forecast kidney comeback in dialysis emergencies
Knowledge-focused CompletedThis completed study looked at 170 adults who needed emergency hemodialysis for acute kidney injury. Researchers measured three blood markers (Activin A, Nostrin, and Angiopoetin-2) before dialysis to see if they could predict whether the kidneys would recover or if the patient w…
Phase: NA • Sponsor: Muğla Sıtkı Koçman University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
Kidney risk after lung surgery: new clues from 150 patients
Knowledge-focused CompletedThis study reviewed the records of 150 adults who had surgery to clear blood clots from the lung arteries. Researchers wanted to see who developed kidney injury within two days after surgery and what factors raised that risk. They looked at things like how long the patient was on…
Sponsor: Ebru Girgin Dinc • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
Scientists create first tools to measure recurrent UTI burden
Knowledge-focused CompletedThis study aimed to develop and test two new questionnaires for people with recurrent urinary tract infections (UTIs). The Recurrent UTI Symptom Scale measures symptom severity, while the Recurrent UTI Impact Questionnaire looks at how the condition affects daily life, work, and …
Sponsor: University of Reading • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
Stretching for musicians: a small study tests if mobility moves improve posture and balance
Knowledge-focused CompletedThis study looked at whether a four-week program of gentle mobilization exercises could improve balance in orchestra musicians, who often stand or sit in awkward positions for long periods. Twenty-three musicians were split into groups that did the exercises once or twice a week.…
Phase: NA • Sponsor: Inonu University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
Antidepressant dose linked to hospital risk in seniors with kidney trouble
Knowledge-focused CompletedThis completed study looked at 5000 older adults (66+) with low kidney function who started taking the antidepressant nortriptyline. Researchers compared those taking more than 10 mg per day to those taking exactly 10 mg per day to see if higher doses increased the chance of an e…
Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
Kidney cancer surgery may raise risk of scrotal swelling, study suggests
Knowledge-focused CompletedThis study reviewed health records of 40,000 men in Ontario, Canada, to see if those who had kidney cancer surgery (nephrectomy) were more likely to develop a hydrocele—a fluid-filled sac in the scrotum. Researchers compared men who had laparoscopic or open surgery to similar men…
Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
Kidney transplant study compares immune effects of two common drugs
Knowledge-focused CompletedThis study looked at 49 kidney transplant patients to see how two different induction therapies—thymoglobulin and basiliximab—affect B cells, a type of immune cell. Researchers compared the B cell profiles between the two groups and with data from patients who had chronic antibod…
Sponsor: University Hospital, Brest • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
Kidney health may change how this drug works
Knowledge-focused CompletedThis study looked at how the drug LY3502970 behaves in people with healthy kidneys compared to those with kidney problems. Researchers measured how much drug gets into the blood and how fast the body clears it. The goal is to understand if kidney impairment changes drug levels, w…
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
Can a phone coach and doctor registry improve kidney care?
Knowledge-focused CompletedThis study looked at two tools to help people with chronic kidney disease (CKD) stay healthier. One tool gave doctors a registry to track patients, and the other offered phone coaching from a health coach. The goal was to see if these approaches could lower blood pressure and imp…
Phase: NA • Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
Hidden kidney risk during nose surgery? new study investigates
Knowledge-focused CompletedThis study looked at whether intentionally lowering blood pressure during nose surgeries (like rhinoplasty) might cause hidden kidney injury. Researchers measured two sensitive kidney biomarkers (NGAL and cystatin C) in 35 adults before and after surgery. The goal was to detect e…
Sponsor: Gazi University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:03 UTC
-
New dialysis fluid tested against standard in small study
Knowledge-focused CompletedThis study looked at how well a new dialysis solution works compared to the usual one in people with kidney failure who are on peritoneal dialysis. Seven stable patients each tried both solutions during a single 4-hour session. The goal was to measure fluid removal and changes in…
Phase: PHASE3 • Sponsor: Karolinska Institutet • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:03 UTC
-
Can exercise strengthen bones in kidney disease? study tests aerobic vs resistance training
Knowledge-focused CompletedThis study looked at how two types of exercise affect bone health in people with chronic kidney disease. Sixty patients did either treadmill walking or resistance training for 6 months. Researchers measured bone turnover markers and bone density before and after the program to se…
Phase: NA • Sponsor: Badr University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:03 UTC
-
Study aims to find best dialysis access for seniors
Knowledge-focused CompletedThis study looked at 166 older adults (65+) on hemodialysis to compare three types of vascular access: fistulas, grafts, and catheters. The goal was to see which option leads to fewer complications and better quality of life. Researchers tracked how many procedures were needed to…
Phase: NA • Sponsor: Maastricht University Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:02 UTC
-
Massive kidney study tracks 3,000 patients over 5 years
Knowledge-focused CompletedThis study followed more than 3,000 adults with moderate to advanced chronic kidney disease (CKD) for up to 5 years. Researchers collected health data and blood/urine samples to identify factors that lead to kidney failure, heart problems, and other complications. The goal was to…
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:02 UTC
-
Could your gut and kidneys be affecting your brain? new MRI study investigates
Knowledge-focused CompletedThis completed study looked at why people with IgA nephropathy (a kidney disease) often experience memory and attention problems. Researchers used powerful 7-Tesla MRI scanners to examine the brains of 100 patients and 100 healthy volunteers, along with analyzing their gut bacter…
Sponsor: Tang-Du Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:01 UTC
-
Kidney check: do current AKI tests really work in the ICU?
Knowledge-focused CompletedThis study looked at 1416 very sick adults in the ICU to see how well different stages of acute kidney injury (AKI) match the kidneys' actual ability to filter waste. Researchers used a urine test to measure kidney function and compared two common ways to diagnose AKI: one based …
Sponsor: University Hospital, Ghent • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Suction vs. no suction: which is safer for kidney stone surgery?
Knowledge-focused CompletedThis study looked at pressure inside the kidney during surgery to remove kidney stones. Twenty-one adults had the procedure with either a suction or a non-suction tube. The goal was to see which method keeps pressure lower, which could make surgery safer and help clear more stone…
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Massive diabetes study tracks thousands over decades to uncover disease secrets
Knowledge-focused CompletedThis long-running study follows over 12,000 people from the Gila River Indian Community in Arizona to understand why type 2 diabetes develops and how it leads to complications. Participants receive regular check-ups every two years, including blood tests and physical exams. The g…
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
AI model could help doctors predict bladder cancer treatment outcomes
Knowledge-focused CompletedThis study developed an AI model to predict how well bladder cancer responds to treatment before surgery. Researchers used data from 469 patients, including medical images and genetic information, to train the AI. The goal is to help doctors choose the best treatment plan for eac…
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Scientists hunt for disease genes in amish and mennonite communities
Knowledge-focused CompletedThis completed study looked at inherited disorders common in Amish and Mennonite populations. Researchers collected medical histories, blood or cheek swab samples from 157 participants to find the genes behind these conditions. They also built a computer database of family trees …
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Massive study reveals hidden dangers of common steroid treatments
Knowledge-focused CompletedThis completed study looked at over 107,000 patients in Germany to understand the long-term side effects of systemic steroids (corticosteroids) used for conditions like asthma, COPD, and arthritis. Researchers compared patients who took steroids with those who did not, tracking r…
Sponsor: GlaxoSmithKline • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Antidepressant doses under scrutiny for kidney patients
Knowledge-focused CompletedThis study examined whether starting a higher dose of two common antidepressants (venlafaxine and duloxetine) increases the risk of emergency visits, hospital stays, or death within 30 days in older adults with chronic kidney disease. Researchers analyzed health records from over…
Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Scientists hunt for clues to kidney damage in sepsis
Knowledge-focused CompletedThis completed study looked at 211 people with sepsis, some of whom also had acute kidney injury. Researchers measured specific microRNAs and other markers in the blood to understand how kidney damage happens. The goal was to find new targets for diagnosis or treatment, not to te…
Sponsor: University Hospital Ostrava • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
New approach to CPR talks may help patients and families feel heard
Knowledge-focused CompletedThis study tested a new way for doctors to discuss CPR with older, seriously ill patients and their families. Instead of the usual conversation, doctors followed a step-by-step guide that focused on the patient's values and explained why CPR might not help. The goal was to see if…
Phase: PHASE2, PHASE3 • Sponsor: University of Vermont • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Kidney stone patients may skip stent after surgery, study hints
Knowledge-focused CompletedThis study looked at whether placing a ureteral stent after ureteroscopy for kidney stones reduces complications. 103 adults with small kidney stones were randomly assigned to get a stent or not. Researchers tracked ER visits, unplanned doctor visits, and hospitalizations to see …
Phase: NA • Sponsor: Vanderbilt University Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Heat wave warning: study reveals how chronic illness patients suffer in high temperatures
Knowledge-focused CompletedThis completed study looked at how rising temperatures affect people with chronic conditions like heart disease, diabetes, and depression. Researchers in Germany and Italy surveyed 176 patients to see what symptoms they experienced during heat and what protective steps they took.…
Sponsor: Universitätsklinikum Hamburg-Eppendorf • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Bladder cancer treatment patterns under the microscope
Knowledge-focused CompletedThis study looks at how adults with advanced bladder cancer are treated in everyday medical practice, not in a controlled trial. Researchers will analyze data from cancer clinics to see how long patients go without their disease worsening after starting their first treatment. The…
Sponsor: Pfizer • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:39 UTC
-
Massive study probes kidney stone risk for living donors
Knowledge-focused CompletedThis study looked at 50,000 living kidney donors in Canada to see if they are more likely to develop kidney stones years after donating, compared to similar people who never donated. Researchers used health records from 1992 to 2024 to track surgeries or hospital visits for kidne…
Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:38 UTC
-
Heartbeat clues to bladder fullness: new study explores Non-Invasive test
Knowledge-focused CompletedThis study tested a new method to measure bladder fullness using heart signals. Researchers placed sticky patches (electrodes) on the body to record the heart's electrical activity during a standard bladder test. The goal was to develop a computer algorithm that could estimate bl…
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:38 UTC
-
App and bottle combo aims to flush away kidney stones
Knowledge-focused CompletedThis study tested a system called sipIT that uses a smart water bottle and phone app to track fluid intake and send reminders. The goal was to see if it helps kidney stone patients form a habit of drinking more fluids. 172 adults with a recent kidney stone diagnosis used the syst…
Phase: NA • Sponsor: University of Michigan • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Massive global study reveals hidden burden of kidney disease in dialysis patients
Knowledge-focused CompletedThis study looked at information from about 70,000 adults receiving hemodialysis around the world to find out how many have IgA nephropathy (a type of kidney disease) and how it affects their health. Researchers compared patients with IgA nephropathy to other dialysis patients to…
Sponsor: Arbor Research Collaborative for Health • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Real-World data reveals how dapagliflozin works for kidney disease
Knowledge-focused CompletedThis completed observational study analyzed electronic health records of nearly 13,000 adults with chronic kidney disease in Spain to see how the drug dapagliflozin is used in everyday practice. Researchers looked at patient characteristics, lab results, and healthcare costs over…
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Sugar-Tweaked heart hormone tested in healthy volunteers
Knowledge-focused CompletedThis early-phase study in 17 healthy male volunteers examines how a natural sugar modification on the heart hormone ANP changes its effects on blood pressure and fluid balance. Participants receive intravenous infusions of both the sugar-modified and unmodified forms of the hormo…
Phase: EARLY_PHASE1 • Sponsor: Peter Fruergaard Andersen • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Kidney function may change how diabetes drug works
Knowledge-focused CompletedThis study looked at how a single dose of HR17031 moves through the body in people with mild, moderate, severe, or end-stage kidney disease compared to those with normal kidneys. A total of 24 adults with type 2 diabetes took part. The goal was to understand how kidney function a…
Phase: PHASE1 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
AR goggles show trainees where experts look during kidney stone surgery
Knowledge-focused CompletedThis study tested an augmented reality tool that shows surgical trainees where an expert surgeon looks during kidney stone surgery. Ten urology residents used the device on kidney models (phantoms). The goal was to see if this eye-gaze guidance helps trainees learn to explore the…
Phase: NA • Sponsor: Vanderbilt University Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Kidney function affects how drug MCI-186 moves through body
Knowledge-focused CompletedThis study looked at how the drug MCI-186 is handled by the body in people with mild or moderate kidney impairment compared to those with normal kidneys. Thirty adults received a single dose of the drug, and researchers measured its levels in the blood. The goal was to understand…
Phase: PHASE1 • Sponsor: Tanabe Pharma Corporation • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
Can mailed videos help more patients get kidney transplants?
Knowledge-focused CompletedThis study tested a home education program called Explore Transplant@Home for nearly 1,000 patients with chronic kidney disease. The program mailed videos, postcards, and texts to teach about kidney transplant options, especially from living donors. The goal was to see if this ap…
Phase: NA • Sponsor: The Methodist Hospital Research Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
New implant aims to simplify dialysis fistula monitoring
Knowledge-focused CompletedThis study tested a new device called EchoMark LP, which is implanted near a surgically created blood vessel connection (fistula) used for dialysis. The device works with a special ultrasound system (EchoSure) to measure blood flow, depth, and diameter of the fistula. The trial i…
Phase: NA • Sponsor: Sonavex, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
Dialysis patients wear heart monitors for a week to uncover hidden risks
Knowledge-focused CompletedThis study followed 268 adults with end-stage kidney disease on dialysis. Each participant wore a Holter heart monitor for 7 days to track irregular heartbeats. Researchers then looked for links between those heart patterns and serious outcomes like sudden cardiac death, heart at…
Sponsor: Rigshospitalet, Denmark • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
Kidney cancer study reveals muscle loss clues in 161 patients
Knowledge-focused CompletedThis study looked at how lifestyle factors like obesity and muscle loss affect kidney cancer risk and survival after kidney removal. Researchers collected blood, tissue, and questionnaire data from 161 patients over up to 5 years. The goal was to understand how to personalize tre…
Sponsor: University of Utah • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
Antibiotics before kidney drainage: help or hype?
Knowledge-focused CompletedThis study looked at whether giving antibiotics before a kidney drainage procedure (called percutaneous nephrostomy) prevents urinary tract infections in cancer patients whose urinary tract is blocked by a tumor. Researchers reviewed records of 320 cancer patients who had the pro…
Sponsor: Barretos Cancer Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
8,000 kidney tumor samples collected to unlock cancer clues
Knowledge-focused CompletedThis completed research study collected and stored tumor tissue, blood, and urine samples from 8,000 children and young adults with kidney tumors. The goal was to help scientists study DNA changes and find biomarkers that could improve understanding of these cancers. No treatment…
Sponsor: Children's Oncology Group • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
Islet transplants after kidney: a game changer for type 1 diabetes?
Knowledge-focused CompletedThis study looked at whether getting an islet transplant after a kidney transplant helps people with type 1 diabetes avoid kidney failure or death. Researchers reviewed data from 327 people in France who had a kidney transplant between 2000 and 2017. They compared those who also …
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:34 UTC
-
AI helps kidney patients discuss future treatment options
Knowledge-focused CompletedThis study tested whether an AI tool that predicts the risk of kidney transplant failure within one year can improve conversations between patients, their families, and doctors. 76 adults with a functioning kidney transplant but declining kidney function took part. The goal was t…
Phase: NA • Sponsor: Charite University, Berlin, Germany • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:34 UTC
-
Gut check: dialysis Patients' microbiome under the microscope
Knowledge-focused CompletedThis study looked at 58 adults on hemodialysis to understand how the mix of bacteria in their gut relates to waste products in their blood. Researchers measured different types of gut bacteria and chemicals they produce, like short-chain fatty acids and uremic toxins. The goal wa…
Sponsor: Tungs' Taichung Metroharbour Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:33 UTC
-
Stent timing may impact kidney stone surgery outcomes
Knowledge-focused CompletedThis study looked at 210 adults who had kidney stone surgery (RIRS) to see if placing a stent before the procedure helped clear stones completely and reduced the need for a second surgery. Researchers compared how long the stent was left in before surgery. The goal is to find the…
Phase: NA • Sponsor: Bedreddin Kalyenci • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:33 UTC
-
Tiny lessons, big recovery: microlearning boosts surgery Know-How
Knowledge-focused CompletedThis study tested whether short, focused lessons (microlearning) can help patients remember important health information and feel more confident after same-day surgery. Researchers enrolled 5 adults scheduled for specific gynecological procedures. Participants completed surveys b…
Phase: NA • Sponsor: University Hospitals Cleveland Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:33 UTC
-
Can estrogen boost the 'Love Hormone' in a rare condition?
Knowledge-focused CompletedThis pilot study tested whether a single dose of oral estrogen-progestin can raise oxytocin levels in people with arginine vasopressin deficiency (AVD), a rare condition that also causes low oxytocin. Researchers compared 28 adults—some with AVD and some healthy—to see if oxytoci…
Phase: EARLY_PHASE1 • Sponsor: Elizabeth Austen Lawson • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:33 UTC
-
Pedaling while dialyzing: exercise may shield hearts of kidney patients
Knowledge-focused CompletedThis study looked at whether a 12-week cycling program during hemodialysis can reduce heart muscle stress (called stunning) in adults with end-stage kidney disease. 111 participants either cycled or rested during their dialysis sessions. Researchers measured heart function with u…
Phase: NA • Sponsor: University of Manitoba • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
Kidney Patients' mouth health under microscope
Knowledge-focused CompletedThis study looked at 88 adults with chronic kidney disease to see how their oral health changes at different stages. Researchers checked teeth, gums, saliva, and breath to find links with nutrition and inflammation. The goal is to understand if dental problems can worsen kidney d…
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
Virtual doctor visits could cut wait times for urology patients in rural nigeria
Knowledge-focused CompletedThis study tested whether telemedicine could help people in rural Nigeria get urology care faster. 220 adults were split into two groups: one had a standard in-person consultation, the other a virtual consultation with a urologist. Researchers measured how long it took to see a s…
Phase: NA • Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
Tiny gold seeds could sharpen radiation for spine tumors
Knowledge-focused CompletedThis study tested whether implanting tiny gold markers near spinal tumors helps deliver radiation more accurately. Researchers also checked if giving slightly more radiation to the nearby esophagus is safe, which might improve tumor control. The study involved 41 adults with vari…
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
Spinal vs general anesthesia: which keeps the penis longer?
Knowledge-focused CompletedThis study compared penile length in 200 adult men undergoing cystoscopy under spinal anesthesia versus general anesthesia. Researchers measured length and asked surgeons to rate satisfaction with access. The goal was to see if anesthesia choice affects penile size during the pro…
Phase: NA • Sponsor: Tanta University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC
-
Video lessons boost kidney transplant knowledge
Knowledge-focused CompletedThis study tested whether a program of videos and text messages (called KidneyTIME) helps people with kidney failure learn more about getting a kidney from a living donor. 422 adults who were already being evaluated for a kidney transplant took part. The study compared those who …
Phase: NA • Sponsor: State University of New York at Buffalo • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC
-
New surgical clip tool tested in 161 patients
Knowledge-focused CompletedThis study looked at a new device called AE05ML that helps surgeons place clips on blood vessels and other tissues during keyhole surgery. The goal was to see if the device is safe and works well. A total of 161 adults took part in the study.
Sponsor: Teleflex • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC
-
Blood marker may flag surgery danger for seniors
Knowledge-focused CompletedThis study looked at nearly 30,000 older adults (65+) having non-cardiac surgery to see if levels of homocysteine, a natural amino acid, could predict serious complications like kidney injury or death. Researchers measured homocysteine before and after surgery. The goal was to se…
Sponsor: Chinese PLA General Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC
-
Brain scans reveal why bladder control fails with age
Knowledge-focused CompletedThis completed study looked at how the brain controls the bladder in older women with urgency urinary incontinence. Researchers used MRI scans to compare brain activity during bladder filling and emptying in 207 women, both young and old, with and without incontinence. The goal w…
Phase: NA • Sponsor: University of Pittsburgh • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
New study aims to take the guesswork out of kidney stone laser surgery
Knowledge-focused CompletedThis study looked at 61 adults with kidney stones to see if stone size and density could predict how much laser energy is needed during a procedure called thulium fiber laser lithotripsy. Researchers used CT scans before surgery to measure stone volume and density, then tracked t…
Phase: NA • Sponsor: Bozok University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
New program helps dialysis patients and families make tough end-of-life decisions together
Knowledge-focused CompletedThis study tested a program called SPIRIT that helps kidney dialysis patients and their families plan for end-of-life care. The program involved two face-to-face sessions to improve communication and decision-making. Researchers enrolled 852 patients and their surrogates from dia…
Phase: NA • Sponsor: Emory University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
Can an app help kidney cancer patients manage treatment side effects?
Knowledge-focused CompletedThis study looked at whether a software program called Carevive could help patients with advanced kidney cancer track side effects from their oral targeted therapy or immunotherapy. 21 patients used the software to report symptoms and received self-care tips. The goal was to see …
Phase: NA • Sponsor: University of Rochester • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
Ultrasound could help doctors manage fluids during kidney treatment
Knowledge-focused CompletedThis study looked at 100 critically ill adults with severe kidney failure who were receiving continuous kidney replacement therapy. Researchers used a special ultrasound technique to check for fluid buildup in the body, which can harm organs. The goal was to see how common fluid …
Sponsor: Chulalongkorn University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
Magnesium levels linked to clotting risk in sepsis
Knowledge-focused CompletedThis study looked at 150 adults with sepsis in the ICU to see if low magnesium levels are connected to blood clotting problems. Researchers measured magnesium and clotting markers at admission and tracked outcomes like DIC and survival. The goal was to understand if magnesium cou…
Sponsor: Ain Shams University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
New formula may help dialysis timing save lives
Knowledge-focused CompletedThis study looked at whether starting dialysis at a specific time, based on a new mathematical formula, could help people with end-stage kidney disease live longer. 388 patients were randomly assigned to start dialysis either at an 'optimal' or 'late' time. Researchers tracked de…
Phase: NA • Sponsor: The First Affiliated Hospital of Dalian Medical University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
New biomarkers may spot kidney trouble after heart surgery
Knowledge-focused CompletedThis completed study looked at over 3,000 heart surgery patients who developed acute kidney injury. Researchers tested new biomarkers to see if they could predict which patients would get worse. The goal is to help doctors identify high-risk patients earlier and improve care.
Sponsor: Guowei Tu • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
Tiny study probes urea breakdown in dialysis patients
Knowledge-focused CompletedThis completed study from Aarhus University looked at how the urea cycle works in 10 people with end-stage kidney disease on dialysis. Participants received a 3-hour alanine infusion, and researchers measured urea production before and after dialysis. The goal was to understand u…
Phase: NA • Sponsor: University of Aarhus • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Which sedation is safer for TAVR? propofol vs dexmedetomidine
Knowledge-focused CompletedThis study compared two common sedation drugs, propofol and dexmedetomidine, in 65 older adults undergoing a less invasive heart valve replacement called TAVR. The goal was to see which drug leads to better kidney function, less confusion, and fewer complications after the proced…
Phase: NA • Sponsor: University of Ioannina • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Lying on your back or belly? study tests lung risk in kidney stone surgery
Knowledge-focused CompletedThis study looked at 200 adults having kidney stone surgery to see if lying on their back versus their belly changes the risk of lung problems after surgery. Researchers measured lung 'mechanical power' during surgery and tracked complications. The goal is to find the safest posi…
Sponsor: TC Erciyes University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Scientists hunt for early warning signs of kidney failure in rare genetic diseases
Knowledge-focused CompletedThis completed study collected blood and urine samples from 240 people with ciliopathies—rare genetic disorders that often lead to kidney failure. Researchers analyzed these samples to find biological markers that could predict how the disease will progress. The goal is to develo…
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Dialysis magnesium mystery: pilot study seeks answers
Knowledge-focused CompletedThis study looked at whether adjusting the amount of magnesium in the dialysis fluid could help keep blood magnesium levels in a healthy range for people with kidney failure on hemodialysis. Fifty-four adults took part in this pilot crossover trial. The goal was to gather informa…
Phase: NA • Sponsor: Universitaire Ziekenhuizen KU Leuven • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Kidney function may change how diabetes drug works
Knowledge-focused CompletedThis study looks at how the body processes HRS9531, an experimental diabetes drug, in people with different levels of kidney function. Researchers gave a single dose to 32 volunteers—some with healthy kidneys and some with mild impairment—and measured drug levels over time. The g…
Phase: PHASE1 • Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
AI vs. jargon: can robots make cancer info easier to read?
Knowledge-focused CompletedThis study tested whether an AI tool can help health providers write medical summaries that are easier for patients to understand. 120 providers were split into two groups: one used the AI tool, the other did not. The goal was to see if AI could improve readability and save time,…
Phase: PHASE2 • Sponsor: University of Southern California • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Emergency dialysis disconnect: do patients know how?
Knowledge-focused CompletedThis study looked at whether people on hemodialysis know how to safely disconnect themselves from the dialysis machine during an emergency, like a fire or power outage. Researchers tested 620 patients from multiple countries using a checklist. The goal was to see if patients coul…
Sponsor: Istanbul University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Kidney stone mystery: why some gene carriers get sick and others stay healthy
Knowledge-focused CompletedThis study looks at people who carry one copy of a mutated AGXT gene, which is linked to a rare kidney stone disease. Some carriers develop kidney stones, while others do not. Researchers will compare their urine oxalate levels and lifestyle factors to find out what triggers symp…
Phase: NA • Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
Video team cuts unnecessary antibiotic use in rural hospitals
Knowledge-focused CompletedThis study tested a program where rural hospitals connect with an infectious disease expert through video calls to improve antibiotic use. The goal was to reduce unnecessary antibiotics and fight drug-resistant infections. Eight VA medical centers participated, and the approach h…
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
Simulation training for dialysis nurses shows promise in reducing needle mishaps
Knowledge-focused CompletedThis study looked at whether adding hands-on simulation training to standard classroom teaching helps nurses cause fewer problems when inserting needles into the arm access (arteriovenous fistula) of dialysis patients. About 9600 adults on chronic hemodialysis took part. The goal…
Phase: NA • Sponsor: University Hospital, Caen • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
Kidney health may change how drug works in body
Knowledge-focused CompletedThis study looked at how different levels of kidney function affect the way the drug enpatoran moves through the body. 34 adults with normal or impaired kidney function received a single dose of enpatoran. Researchers measured drug levels in the blood and monitored for side effec…
Phase: PHASE1 • Sponsor: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
Patients and doctors rank top priorities for kidney disease Self-Care
Knowledge-focused CompletedThis completed study asked 140 people—including patients with chronic kidney disease, their families, healthcare professionals, and researchers—to identify the most important outcomes for self-managing the condition before dialysis is needed. Through multiple survey rounds, parti…
Sponsor: University of Leicester • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:27 UTC
-
Bowel troubles may slow recovery after prostate surgery
Knowledge-focused CompletedThis study looked at 120 men who had HoLEP surgery for an enlarged prostate. Researchers wanted to see if bowel problems before surgery made recovery harder. Patients filled out questionnaires about bowel and urinary symptoms before and after surgery. The goal was to learn how bo…
Sponsor: Northwestern University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:26 UTC
-
New conversation tool aims to improve End-of-Life care for kidney patients
Knowledge-focused CompletedThis study tested a communication tool called 'Best Case/Worst Case' for older adults with advanced kidney disease. Doctors were trained to discuss best, worst, and most likely outcomes for treatment options. The goal was to see if this approach helps patients receive more pallia…
Phase: NA • Sponsor: University of Wisconsin, Madison • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:26 UTC
-
Running and swimming may temporarily stress kidneys, study finds
Knowledge-focused CompletedThis study looked at how a 10 km run and a 1.5 km swim affect kidney function in 40 healthy, active adults. Researchers used sensitive urine tests to detect subtle kidney changes that standard blood tests might miss. The goal was to better understand temporary kidney stress from …
Phase: NA • Sponsor: Hospital Clínico Universitario de Valladolid • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:26 UTC
-
Kidney drug combo under microscope: can they keep fluids in check?
Knowledge-focused CompletedThis completed Phase 2 study investigated how the drugs dapagliflozin and balcinrenone, alone or together, affect the body's handling of water and salts in people over 50 with stage 3 chronic kidney disease. Over 28 days, 103 participants took daily pills to measure changes in ur…
Phase: PHASE2 • Sponsor: Klinikum Nürnberg • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:25 UTC
-
New survey aims to uncover hidden needs in bladder cancer care
Knowledge-focused CompletedThis completed study involved 93 adults with stage 4 incurable bladder cancer. Participants completed surveys and focus groups to identify their supportive care and educational needs. The goal was to design a screening tool to help healthcare teams better address these needs in t…
Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:25 UTC
-
Transplant lifesaver linked to cancer risk: study investigates
Knowledge-focused CompletedThis study looked at 2,500 kidney transplant patients to find out why some develop cancer. The main focus was on the immunosuppressive drugs that prevent organ rejection, which can also raise cancer risk. Researchers tracked patients from four regions in France over 10 years to i…
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:25 UTC
-
Large study tracks kidney disease progression in thousands of patients
Knowledge-focused CompletedThis study followed over 3,400 people with autosomal dominant polycystic kidney disease (ADPKD) to learn how the disease progresses. Researchers measured kidney size, symptoms, quality of life, and healthcare costs. The goal was to identify factors that predict faster disease pro…
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
Harmless virus levels may predict transplant complications
Knowledge-focused CompletedThis study looked at 172 kidney transplant recipients who were on stable anti-rejection medication for at least 3 months. Researchers measured levels of a common, harmless virus (Torque Teno Virus) in their blood to see if it could predict serious infections or organ rejection. T…
Sponsor: Singapore General Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
New online tool aims to help bladder cancer patients navigate tough treatment choices
Knowledge-focused CompletedThis study tested a new online tool called the Personal Patient Profile for Bladder Cancer (P3BC) in 24 patients who were facing bladder removal surgery. The tool provides personalized information, videos, and summaries to help patients talk with their doctors and prepare for rec…
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
Personalized mutation tracking could spot relapse sooner in bone marrow cancer patients
Knowledge-focused CompletedThis study looked at 308 people with myelodysplastic syndromes (MDS) who had a stem cell transplant. Researchers identified each patient's unique genetic mutations and then monitored those mutations in blood and bone marrow samples after transplant. The goal was to see if rising …
Sponsor: Nordic MDS Group • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Kidney health may change how drug works in body
Knowledge-focused CompletedThis study looked at how the drug LY3537031 moves through the body in people with different levels of kidney function. It included 31 adults with normal kidneys, kidney impairment, or end-stage kidney disease. The goal was to measure drug levels in the blood and how long it takes…
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Brain scans reveal secrets of bladder leaks in women over 60
Knowledge-focused CompletedThis study looked at how the brain works in women aged 60 and older who have sudden, strong urges to urinate (urgency urinary incontinence). Participants took a medication called trospium or a placebo, and had brain scans (MRI) to see if changes in brain activity relate to fewer …
Phase: PHASE4 • Sponsor: Becky Clarkson • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
New approach aims to catch kidney disease earlier in hispanic and black communities
Knowledge-focused CompletedThis study worked with community groups to screen Hispanic/Latinx adults for kidney disease and diabetes, then referred them to a primary care doctor. It also gave local clinics guidelines to help doctors screen and treat Hispanic and Black patients with diabetes. The goal was to…
Sponsor: Duke University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Which IV fluid spares kidneys best during back surgery in seniors?
Knowledge-focused CompletedThis study looked at 174 older adults (ages 65-80) having lumbar fusion surgery to see whether using sodium acetate Ringer's solution or sodium lactate Ringer's solution during the operation better protects the kidneys. Researchers measured early kidney injury markers in urine an…
Phase: NA • Sponsor: Xianping Wu • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Kidney function may change how this drug works
Knowledge-focused CompletedThis completed Phase 1 study looked at how the drug LY3537982 is processed in people with different levels of kidney function. Researchers compared 32 participants with normal kidneys, moderate kidney problems, and severe kidney problems. The goal was to see how kidney impairment…
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Scientists hunt for clues to why immunotherapy fails in most patients
Knowledge-focused CompletedThis study looked at 135 people with advanced lung cancer, lymphoma, or other tumors treated with immunotherapy drugs called checkpoint inhibitors. Researchers collected blood and tumor samples over time to measure immune cells and molecules that might predict whether the treatme…
Phase: NA • Sponsor: Institut Paoli-Calmettes • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Scientists collect kidney samples from COVID-19 patients to uncover clues about organ damage
Knowledge-focused CompletedThis completed study collected blood, urine, and kidney tissue from 90 COVID-19 patients with acute kidney injury. Researchers aimed to build a biorepository and analyze samples to better understand how COVID-19 affects the kidneys. The goal is to speed up discoveries and improve…
Sponsor: University of Washington • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Dialysis danger: what causes blood pressure to crash during treatment?
Knowledge-focused CompletedThis study looked at 395 adults on long-term dialysis to find out how often their blood pressure drops dangerously during treatment and what makes it more likely. Researchers collected information on patients' health history, medications, and dialysis settings. The goal is to hel…
Sponsor: First Affiliated Hospital of Wannan Medical College • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
AR goggles could help surgeons see kidney stones better
Knowledge-focused CompletedThis study tested an augmented reality (AR) tool that tracks where a surgeon looks during kidney stone surgery. The goal was to help trainee surgeons learn to find all stone fragments, which could reduce repeat surgeries. Eight urology residents participated in a simulated settin…
Phase: NA • Sponsor: Vanderbilt University Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:10 UTC
-
Balloon or tube? study tests which catheter keeps kidney stone fragments in place
Knowledge-focused CompletedThis completed study looked at 108 adults having surgery for kidney stones. It compared a balloon-tipped catheter to a standard small tube to see which one better prevents stone fragments from moving into the ureter. The goal is to help surgeons choose the best tool for the job.
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:09 UTC
-
Massive study probes cancer risk of common diabetes drug
Knowledge-focused CompletedThis completed study analyzed health records from over 2 million people with type 2 diabetes to see if those taking dapagliflozin had a different risk of breast or bladder cancer compared to those on other diabetes medications. Researchers tracked cancer diagnoses for up to 12 ye…
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:09 UTC
-
Sharper scans during radiation: a pilot study
Knowledge-focused CompletedThis study tested whether a new type of CT scan (dual energy CT) can produce clearer images of tumors during radiation therapy. Researchers compared the new scan to the standard scan in 30 adults receiving radiation for pelvic or genitourinary cancers. The goal was to see if the …
Sponsor: University of Michigan Rogel Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC
-
Health card data may guide UTI treatment
Knowledge-focused CompletedThis study looked at whether information from national health insurance cards—like past antibiotic use and hospital stays—can predict if a person's urinary tract infection will be resistant to common antibiotics. Researchers analyzed data from over 1,100 patients with community-a…
Sponsor: University Hospital, Rouen • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC
-
New study reveals hidden kidney risks in liver cirrhosis patients
Knowledge-focused CompletedThis study looked at how often acute kidney injury happens in people with liver cirrhosis, and what factors might increase the risk. Researchers at Sohag University Hospital followed 180 adult patients with cirrhosis, excluding those with pre-existing kidney disease or other majo…
Sponsor: Sohag University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
Real-World data on kidney drug finerenone in chinese patients
Knowledge-focused CompletedThis completed study analyzed electronic health records from over 6,500 patients in China who started taking finerenone for chronic kidney disease and type 2 diabetes. Researchers tracked kidney function, potassium levels, and side effects like high potassium. The goal was to see…
Sponsor: Bayer • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
Ready-to-use dialysis fluids tested in real-world ICU study
Knowledge-focused CompletedThis study tracked 228 critically ill patients in China who needed continuous kidney dialysis. Doctors used pre-mixed solutions instead of custom-mixed ones to see how well they worked in everyday hospital care. The goal was to gather information on filter life, blood chemistry, …
Sponsor: Vantive Health LLC • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
Salt levels may change how diabetes drug works on kidneys
Knowledge-focused CompletedThis study looked at how the amount of salt in the diet changes the effects of the diabetes drug ertugliflozin on blood pressure and kidney function. Overweight adults with type 2 diabetes followed either a low-salt or high-salt diet while taking the drug or a placebo. The goal w…
Phase: PHASE4 • Sponsor: Amsterdam UMC, location VUmc • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
New tool helps kidney patients decide on organ offers
Knowledge-focused CompletedThis pilot study tested a shared decision-making tool called the Donor Offer Plan (DOP) for people on the kidney transplant waiting list. 100 participants reviewed an online education module and discussed their donor preferences with a transplant nurse. The goal was to see if thi…
Phase: NA • Sponsor: Hennepin Healthcare Research Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC